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I. GENERAL ISSUES IN THE LAW AND ETHICS OF
PSYCHOSOCIAL RESEARCH
A. The Nature of the Issues
Few topics of legal and ethical inquiry raise so starkly the proper
ordering of the interests of society and the individual as does research
with human participants.' Such research is important to understanding the human condition and advancing human welfare, 2 but it requires using people-making them the subjects3 of the researcher's
investigation. Participants rarely stand to gain direct significant benefit from their investment of time and energy. 4 At most, they typically
acquire whatever good feeling comes from altruism,5 perhaps some in1. See generally G. ANNAS, L. GLANTZ & B. KATZ, INFORMED CONSENT TO HUMAN
EXPERIMENTATION (1977); B. BARBER, J. LALLY, J. MAKARUsKA & R. D. SULLIVAN, RESEARCH ON HUMAN SUBJECTS (1973); THE ETHICS OF SOCIAL RESEARCH (J.
Sieber ed. 1982) [hereinafter cited as SOCIAL RESEARCH]; B. GRAY, HUMAN SUBJECTS IN MEDICAL EXPERIMENTATION (1975); J. KATz, EXPERIMENTATION WITH
HUMAN BEINGS: THE AUTHORITY OF THE INVESTIGATOR, SUBJECT, PROFESSIONS,
AND STATE IN THE HUMAN EXPERIMENTATION PROCESS (1972); NAT'L COMM'N FOR
THE PROTECTION OF HUMAN SUBJECTS OF BIOMEDICAL & BEHAVIORAL RESEARCH,
THE BELMONT REPORT: ETHICAL PRINCIPLES AND GUIDELINES FOR THE PROTECTION OF HUMAN SUBJECTS OF RESEARCH (1979) [hereinafter cited as BELMONT
REPORT].

2. Advances in empirical knowledge of most important aspects of human behavior
and experience require research with human participants: e.g., health; mental
health; crime; consumer behavior; organizational functioning;, education; human
factors in productivity, use of machines, and function of architectural design; family relationships; race relations; and conflict and conflict resolution.
3. Although use of the term subject is common in human research, see, e.g., Protection of Human Subjects, 45 C.F.R. pt. 46 (1984), we will rely upon the term participant,to connote the partnership between researcher and participant, and the
latter's autonomy in deciding whether to become involved in a study. Cf.J. KATZ,
THE SILENT WORLD OF DOCTOR AND PATIENT (1984) (exploring the dynamics and
ethics of the status of physician and patient in decisions about treatment).
4. Whether participants will obtain direct benefit from a study changes the calculus
in the level of risk permissible in research involving participants who may be
unable to give fully competent, voluntary consent. See, e.g., Additional Protections Pertaining to Biomedical and Behavioral Research Involving Prisoners as
Subjects, 45 C.F.R. §§ 46.301 to 46.306 (1984) [hereinafter cited as Protections for
Prisoners]; Additional Protections for Children Involved as Subjects in Research,
45 C.F.R. §§ 46.401 to 46.409 (1984).
5. The potential moral benefit to participants from doing good for society has been a
focus of the debate on whether children should be permitted to participate in
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tellectual stimulation,6 and possibly token sums of money or other
compensation.' In short, research with human participants is typically
for the social good, not the welfare of the individual.
Complicating the situation is the fact that researchers' interests
may not be coextensive with those of society. Academic inquiry is generally assumed to be in the public interest, especially when the topic of
investigation is consensually acknowledged to be a matter of great
public concern.8 However, even in cases in which the topic is a matter
of great moment-perhaps especially in such circumstances-researchers have substantial property interests in their work.9 Tenure,
promotion, merit pay, and the esteem of peers and the educated public
all may be contingent upon conduct of research of ample quantity and
significance. For scholars in disciplines in which human behavior,
anatomy, or physiology is the topic of inquiry,O investment by human
participants in their research is crucial to economic and social status.
Whatever the benefits to the public and the risks to participants in
such research, scholars have a vested interest in stimulating participation in research and guarding the conditions under which research is
conducted and the findings are disseminated."
research even when they are incompetent to consent to it. See, e.g., McCormick,
Experimentationin Children:Sharingin Sociality, HASTINGS CENTER REP., Dec.
1976, at 41; Ramsay, Children as Research Subjects: A Reply, HASTINGS CENTER
REP., Apr. 1977, at 40; Ramsay, The Enforcement of Morals: NontherapeuticResearch on Children,HASTINGS CENTER REP., Aug. 1976, at 21.
6. The use of undergraduates in research to fulfill course requirements is justified
by the knowledge about the research endeavor that is expected to accrue to participants. COMM. FOR THE PROTECTION OF HUMAN PARTICIPANTS IN RESEARCH of
the AM. PSYCHOLOGICAL Ass'N, ETHICAL PRINCIPLES IN THE CONDUCT OF RESEARCH WITH HUMAN PARTICIPANTS 32-33 (1982) [hereinafter cited as APA, COM-

MENTARY ON ETHICAL PRINCIPLES].
7. There is a paradox of purpose in compensation of participants in research from
which they would not otherwise obtain benefit. On the one hand, some compensation is ethically desirable and perhaps pragmatically necessary in order to obtain volunteers for research that is especially time-consuming, tedious, or risky.
On the other hand, the principle of distributive justice requires that risks associated with research should not be borne exclusively by those particularly in need
of money or other benefits. The irony is that adequate compensation may be perceived as diminishing voluntariness of consent. See, eg., Protections for Prisoners, supra note 4, at §§ 46.305(2), (6).
8. See, e.g, Dow Chem. Co. v. Allen, 672 F.2d 1262, 1275 (7th Cir. 1982); Andrews v.
Eli Lilly & Co., 97 F.R.D. 494, 500-03 (N.D. 1. 1983); Richards of Rockford, Inc. v.
Pacific Gas & Elec. Co., 71 F.R.D. 388, 400 (N.D. Cal. 1976).
9. See, e.g., Dow Chem. Co. v. Allen, 672 F.2d 1262, 1276 (7th Cir. 1982); Andrews v.
Eli Lilly Co., 97 F.R.D. 494, 500-03 (N.D. Ill. 1983).
10. Disciplines in which research often requires human participants are wide-rangin- e.g., psychology, sociology, anthropology, marketing, economics, education,
political science, biology, medicine and the other health sciences, and home
economics.
11. See generally D. NELKIN, SCIENCE AS INTELLECTUAL PROPERTY: WHO CONTROLS

SCIENTIFIC RESEARCH? (1984). The protection of trade secrets in business is
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Although there may be few "mad scientists" flagrantly exploiting
and harming participants for a bit of knowledge (and the prestige and
pecuniary benefits that accrue from it), there have been a number of
controversial experiments in recent decades that have stimulated regulation of human research, both by government and the scientific professions themselves. Doubtless, the most notorious examples were
Nazi physicians' gruesome experiments on concentration camp prisoners.12 These led to the promulgation of the Nuremberg Code,13 which
remains the most comprehensive, and perhaps the most restrictive,14
statement of the law of informed consent to research. In addition,
concern over several American medical studies in which participants
were subjected to harmful stimuli15 led to additional professional
guidelines 16 and, ultimately, federal regulation.17
The potential risks to participants from biomedical research are
easy to comprehend. When participants ingest an untried drug, they
are obviously assuming an unknown risk to their health. If healthy,
they may subject themselves to unnecessary physical harm, and, if ill,
they risk exacerbating their prexisting medical condition, losing access
to existing, more effective treatments, and acquiring new medical
problems. Even relatively innocuous medical studies may involve
some discomfort that would not otherwise be incurred, for example,
having one's finger pricked for a blood sample.
analogous. See, e.g., Andrews v. Eli Lilly Co., 97 F.R.D. 494, 501-02 n.24 (N.D. Ill.
1983).
12. See United States v. Brandt, reprintedin 1-2 TRIALS OF WAR CRIMINALS BEFORE
THE NUREMBERG MILITARY TRIBUNALS

(1948).

13. NUREMBERG CODE, reprintedin 143 Sci. 553 (1964).
14. The Nuremberg Code prohibits any research in which participants have not given
fully informed consent. Id. at § 1. Therefore, it bars any research involving persons who, because of immaturity or mental disability, are incompent to consent to
research. It also bars any research using deception or incomplete disclosure.
15. See, e.g., The Jewish ChronicDiseaseHospitalCase, in J. KATZ, supra note 1, at 9;
Benson & Smith, The HarvardDrug Controversy:A Case Study of Subject Manipulation and Social Structure, in ETHICS, POLITICS, AND SOCIAL RESEARCH (G.
Sjoberg ed. 1967); Goldby, Experiments at the Willowbrook State School, 1 LANCET 749 (1971).
16. E.g., AM. ANTHROPOLOGICAL ASS'N, PRINCIPLES OF PROFESSIONAL RESPONSIBILTry (1971); AM. MED. ASS'N, ETHICAL GUIDELINES FOR CLINICAL INVESTIGATION
(1966); AM. SOCIOLOGICAL ASS'N, CODE OF ETICS (1971); DECLARATION OF HELsINKI, RECOMMENDATIONS GUIDING DOCTORS IN CLINICAL RESEARCH (1964);
SOC'Y FOR RESEARCH IN CHILD DEV., ETHICAL STANDARDS FOR RESEARCH WITH
CHILDREN (1973); Am. Psychological Ass'n, EthicalPrinciplesof Psychologists,36
AM. PSYCHOLOGIST 633 (1981) [hereinafter cited as APA Principles]. See also
APA, COMMENTARY ON ETHICAL PRINCIPLES, supra note 6 (commentary on Ethical Principles of Psychologists). A detailed discussion of the manner in which
these and other professional codes strive to protect privacy may be found in Winslade & Ross, Privacy,Confidentialityand Autonomy in Psychotherapy,64 NEB.
L. REv. 578 (1985).
17. Protection of Human Subjects, 45 C.F.R. pt. 46 (1984).
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Although there have been a few dramatic examples of social science research of questionable ethics,' 8 most human research in the
social sciences involves no obvious risk of harm. It is likely few people
would be outraged by its continuation absent any regulation. For example, the greatest risk to participants in most studies in cognitive
psychology is probably boredom,19 a consequence that is unlikely to
stimulate a great social movement for reform.
Nonetheless, the basic dilemma of the proper use of individuals for
the good of society and/or the researcher is present even in social science research.2 0 At a minimum, the research usually requires investment of participants' time without clear benefit to the participants
themselves. Moreover, although participants may not be harmed by
psychosocial research, they still may be wronged through unethical or
questionable ethical practices. Perhaps the most controversial and obvious example of such a practice is the use of deception in social psychological experiments. 21 Even if there is no effect from being the
target of lies by an investigator, the manipulation of the participant in
such a way may violate moral imperatives. 22 A more subtle issue is
that much psychological and sociological research involves private as18. E.g., L. HUMPHREYS, TEAROOM TRADE: IMPERSONAL SEX IN PUBLIC PLACES (1970);
S. MILGRAM, OBEDIENCE TO AUTHORITY: AN EXPERIMENTAL VIEw (1974); Middlemist, Knowles & Matter, PersonalSpace Invasions in the Lavatory:Suggestive
Evidencefor Arousal, 33 J. PERSONALITY & Soc. PSYCHOLOGY 541 (1976). See also
Baumrind, Some Thoughts on Ethics of Researchk After Reading Milgram's Behavioral Study of Obedience, 19 AM. PSYCHOLOGIST 421 (1964); Koocher, Bathroom Behaviorand Human Dignity, 35 J. PERSONALITY & SOC. PSYCHOLOGY 120
(1977) (discussing Middlemist, Knowles & Matter, supra). See generally SOCIAL
RESEARCH, supra note 1.
19. APA, COMMENTARY ON ETHICAL PRINCIPLES, supra note 6, at 17. The participants task might include tracking movement of a light, memorizing pairs of nonsense syllables, or pressing a button whenever a particular symbol appears on a
screen. Such studies sometimes include hundreds of trials. Participants will
sometimes sit for hours complying with an experimenter's request to engage in a
meaningless task, such as adding columns of numbers repeatedly or tearing strips
of papers. See generally Orne, On the Social Psychology of PsychologicalExperiment. With ParticularReference to Demand Characteristicsand their Implications, 17 AM. PSYCHOLOGIST 776 (1962).

20. See Cassell, Harms, Benefits, Wrongs, and Rights in Fieldwork, in SOCIAL RESEARCH: FmLDWORK, REGULATION, AND PUBLICATION, supra note 1, at 7. Sieber,
Ethical Dilemmas in Social Research, in SOCIAL RESEARCH: SURVEYS AND EXPER-

IMENTS, supra note 1, at 1.
21. See, e.g., Adair, Dushenko, & Lindsay, Ethical Regulations and their Impact on
Research Practice,40 AM. PSYCHOLOGIST 59 (1985); Baumrind, Research Using Intentional Deception: Ethical Issues Revisited, 40 AM. PSYCHOLOGIST 165 (1985);
Geller, Alternatives to Deception: Why, What and How?, in SOCIAL RESEARCH:
SURVEYS AND ExPERmmNTS, supra note 1, at 39; Kelman, Human Use of Human
Subjects: The Problem of Deception in Social Psychological Experiments, 67 PSYCHOLOGICAL BULL. 1 (1967); Smith, Some Perspectiveson Ethical/PoliticalIssues
in Social Science Research, 2 PERSONALITY & SOC. PSYCHOLOGY BULL. 445 (1976).
22. See generally S. Box, LYING: MORAL CHOICE IN PUBLIC AND PRIVATE LIFE (1978);
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pects of individual and group behavior.23 As such, there is some intrusiveness involved. Simply asking questions about personal matters or
"unobtrusively" observing behavior 24 may inherently involve a cost in
participants' privacy.
B.

The Ethical and Legal Framework

Recognizing these ethical problems and the potential conflicts of
interest among social scientists, the public, and participants, the relevant professional organizations and the federal government have enacted codes of ethics for the conduct of social science research
involving human participants. 25 The most detailed code is that of the
American Psychological Association (APA).26 The overriding obligation imposed on psychologists by their ethical principles is to "respect
the dignity and worth of the individual and strive for the preservation
and protection of fundamental human rights."27 Researchers must
consider the welfare of participants 28 and guard their civil rights.29
This basic emphasis on the integrity and worth of the individual is
balanced by the responsibility to use professional skills to increase
knowledge useful in the promotion of human welfare.3 0 These general principles are set forth in ten principles, all with amplification in
subprinciples, totaling six pages. There are references to research ethics throughout the ethical principles 31 and, as psychologists, researchers are bound by the principles as a whole. The specific framework for
Freedman, Man Bites Dog: A Bioethicist's Deception, 5(5) IRB 8 (1983); Murray,
Was this Deception Necessary?, 2(10) IRB 7 (1980).
23. See generally Ruebhausen & Brim, Privacy and BehavioralResearch, 65 COLUM.
L. REV. 1184 (1965).
24. Unobtrusive measurement refers to research in which participants are studied
without their knowledge. See generally E. WEBB, D. CAMPBELL, R. ScHwARTz &
L. SECHREST, UNOBTRUSIVE MEASURES: NONREACTIVE RESEARCH IN THE SOCIAL
SCIENCES (1966).

25. Protection of Human Subjects, 45 C.F.R. pt. 46 (1984); AM. ANTHROPOLOGICAL
ASS'N, supra note 16; AM. SOCIOLOGICAL ASS'N, supra note 16; SOC'Y FOR RESEARCH IN CHILD DEV., supra note 16; APA Principles, supra note 16.
26.

27.
28.
29.
30.
31.

APA Principles, supra note 16. See also COMMENTARY ON ETHICAL PRINCIPLES,

supra note 6.
APA Principles, supra note 16, at 633 (Preamble).
Id. at 633, 636, 637-38 (Preamble, Principles 6 & 9).
Id. at 634 (Principle 3c).
Id. at 633, 637-38 (Preamble & Principle 9).
See, e.g., id. at 633 (Principle la) (reporting of research so as to minimize misleading and prejudicial uses of research); id. (Principle 1b) (clarification in advance of
expectations for sharing of research); id. at 634 (Principle 3d) (conflicts between
ethics and law); id at 635 (Prin. 5c) (confidentiality of records); id at 637 (Principle 7e) (obtaining approval for research in institutions or organizations); id.
(Principle 7f) (distribution of publication credit); id. at 638 (Principle 10) (research with animals).
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research with human participants is found in Principle

9.32 The principles relating to research are periodically revised and interpreted by
the APA Committee for the Protection of Human Participants in Research and the APA Ethics Committee, the latter of which also adjudicates complaints relating to possible ethical violations.
The primary legal framework for the protection of human participants in social science research is found in the regulations of the Department of Health and Human Services.3 3 The regulations are based
on the work of the National Commission for the Protection of Human
Subjects of Biomedical and Behaviorial Research34 and its successor,
the President's Commission. 35 In a document known as the Belmont
Report,3 6 the National Commission stated three basic ethical principles that should govern research with human participants. First, respect for persons entails "the requirement to acknowledge autonomy
37
and the requirement to protect those with diminished autonomy."
Second, the principle of beneficence requires the avoidance of harm
and the maximization of possible benefits.3 8 Third, the principle of
justice mandates fair distribution of the burdens of participation in research and of assumption of risks associated with research.3 9
In view of the similar value placed on human dignity and welfare,
it is not surprising that the procedures established as requirements of
professional ethical practice by the Ethical Principles of Psychologists
and as requirements of law by the federal regulations are very similar.
Both require minimization of risk to participants 40 and weighing of
risks and benefits to ensure that the study is worth doing.41 The investigator is obligated to seek ethical advice in determining that the
potential benefits of the study substantially outweigh risks associated

32. Principle 9, id. at 637-38, consists of a preamble and 10 sub-principles. The principle is organized roughly around the chronology of the design, conduct, analysis,
and reporting of a study.
33. Protection of Human Subjects, 45 C.F.R. pt. 46 (1984). All research funded by the
Department of Health and Human Services (HHS) is covered by the regulations.
45 C.F.R. § 46.101(a) (1984). Institutions receiving funds from HHS also must
make provisions for review of research involving human participants that is not
federally funded, 45 C.F.R. § 46.103(a)(1) (1984). As a practical matter, this section of the regulations makes them applicable to all research conducted by universities, schools, and health care facilities.
34. The Commision was authorized by statute. See National Research Act, Pub. L.
93-348, 88 Stat. 342, 348 (1974).
35. Public Health Service Act, 42 U.S.C. § 300v (1982).
36. BELMONT REPORT, supra note 1.
37. Id. at 4.
38. Id. at 4-5.
39. Id. at 5.
40. 45 C.F.R. § 46.111(1) (1984); APA, supra note 16, at 637-38 (Principles 9, 9b, & 9g).
41. 45 C.F.R. § 46.111(2) (1984); APA, supra note 16, at 633, 637 (Principles la, 9, &
9a).
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with the research procedures.42 As a general rule, researchers are required to seek informed consent from participants, 43 honor their freedom not to participate or to withdraw from participantion, 44 and
protect their privacy and the confidentiality of data.45 The Ethical
Principles of Psychologists go beyond the federal regulations to require not only that the design and conduct of research are in accordance with basic ethical principles, but that the results are reported in
ethical fashion.46 Psychologists are obligated to "minimize the possi-

bility that their findings will be misleading ... especially where their
work touches on social policy or might be construed to the detriment
of persons in specific age, sex, ethnic, socioeconomic, or other social
48
groups." 47 At the same time, they are supposed not to suppress data.
II.
A.

THE NATURE AND EPIDEMIOLOGY OF AIDS

Factors Contributing to the Sensitivity of Research on AIDS

The conflicts of interest that sometimes arise in psychosocial research-and the ethical and legal problems that result-are illustrated
most vividly by research on socially sensitive topics. 49 Generally, such
topics involve matters of great public import. In order for policy about
such matters to develop rationally, relevant knowledge is needed. In
some sense, this need is most acute for the groups under study.5 0 On
42. Under the federal regulations, 45 C.F.R. pt. 46 (1984), most research is subject to
review by an institutional review board (IRB) composed of representatives of diverse disciplinary and social backgrounds. Id. at §§ 46.107 & 46.109. The Ethical
Principles also place an obligation on investigators to seek ethical advice. APA
Principles, supra note 16, at 637 (Principle 9a).
43. 45 C.F.R. §§ 46.111 (d)(4)-(5) & 46.116-17 (1984); APA Principles, supra note 16, at
636 & 638 (Principles 6 & 9d).
44. 45 C.F.R. §§ 46.111.(8) and 46.116(8); APA Principles, supra note 16, at Prin. 9f.
45. 45 C.F.R. § 46.111(a)(6) & 46.116(5) (1984); APA Principles, supra note 16, at 633,
635-36, 638 (Principles lb, 5, 5b, 5c & 9j).
46. APA Principles, supra note 16, at 633, 634-35 (Preamble, Principles la & 4). IRBs
are forbidden to consider long-range effects of a study in determining whether to
approve it. 45 C.F.R. § 46.111(a)(2).
47. APA Principles, supra note 16, at 633 (Principle la).
48. Id.
49. See generally Socially Sensitive Researchv Contemporary Ethical and Professional Dilemmas (B. Stanley chair) (symposium presented at the meeting of the
Am. Psychological Ass'n, Los Angeles, Aug. 26, 1985, to be published in AM.
PSYCHOLOGIST).

50. Research involving socially disadvantaged groups may be important to learning
ways of alleviating their condition, although it may also result in "blaming the
victim" and explaining away their "deficits." See, e.g., W. RYAN, BLAMING THE
VIcrIM (rev. ed. 1976); Levine, Old People Are Not All Alike: Social Class, Ethnicity/Race, and Sex Are Bases for Important Differences, in SOCIAL RESEARCH:
SuRVEYs AND EXPERIMENTs, supra note 1, at 127; Loo, Vulnerable Populations:
Case Studies in CrowdingResearch, in SOCIAL RESEARCH: SURVEYS AND EXPFUMENTS, supra note 1, at 127.
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the other hand, socially sensitive research by definition is such that
breaches of confidentiality or careless reporting of findings may result
in harm to participants and the classes they represent. When the topic
is not only socially sensitive but developing amidst great publicity and
intense public interest--even hysteria-the clash of interests (and of
ethical principles) becomes especially acute. For neither the public,
the groups under study, nor the participants themselves is there likely
to be the opportunity to postpone research for a period of sober
reflection.
Research on acquired immune deficiency syndrome (AIDS)
presents just a situation. To appreciate the conflicts engendered by
psychosocial research on AIDS, it is necessary to have some knowledge of the nature and epidemiology of the illness. Four factors have
contributed to the sensitivity of research on AIDS.
First, only particular classes of people, most of them already vulnerable to social stigma and even criminal penalties, have been identified as being at risk for AIDS. The groups at highest risk for
acquisition of AIDS are gay and bisexual men,51 and intravenous drug
users. 52 Haitian immigrants, some of whom are illegal aliens, were
until recently also considered to be a group at risk for AIDS.53 Thus,
the mere identification of participants for research, especially if less
than fully confidential, may subject them to harm.54 Reporting the
results across social groups may serve to exacerbate the stigma already
55
experienced by the groups under study.
A second and related point is that research on AIDS inevitably carries the investigator into highly sensitive and personal areas. As
would be suggested by the characteristics of the groups at risk, transmission of AIDS is believed to occur only through exchange of bodily
fluids, such as certain sexual contact, sharing of needles for intravenous injections, or sharing of blood during transfusions or pregnancy
51. Centers for Disease Control, Update: Acquired ImmunodefIciency Syndrome United States, 34 MoRBIDrrY AND MORTAUTY WEEKLY REP. 245, 246 (1985) [hereinafter cited as CDC]. Gay and bisexual men comprise 73.4 percent of AIDS
patients.
52. IV drug users make up 17.0 percent of the AIDS patients. Id. at 246.
53. Healthy Haitain-American immigrants are more likely than other Americans to
be HTLV-III positive, but it now appears that the risk factors among Haitians are
not unique. Therefore, they have been removed as a special risk group. Id. at 247.
The inclusion of Haitians as a risk group exacerbated political tensions between
the United States and Haiti. See Panem, AIDS, Public Policy and Biomedical
Research, 85 CHEST 416, 417-18 (1984).
54. Hemophiliacs, for example, may become stigmatized because of their risk of acquiring AIDS through contaminated transfusions. Transfusion recipients constitute 1.4 percent of AIDS patients. CDC, supra note 51, at 246.
55. See supra notes 49 and 50.
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(to the fetus).56 There is no evidence that transmission can occur
through casual skin contact or by airborne, respiratory means. 57 To
understand the mode of transmission fully requires the gathering of
data regarding details of sexual practices, drug use, travel, and associations, not only of AIDS patients themselves, but also, their lovers and
friends, members of groups at risk, and control groups.5 8 Moreover, to
test particular hypotheses about modes of transmission may require
some intrusion into privacy simply in obtaining the sample, even
before any questions are asked. For example, in one study determining the nature of sexual practices differentiating gay men who were at
especially high risk for AIDS, one sample was obtained by stopping
men as they left bathhouses and asking them to participate in the
study.59
Third, AIDS appeared suddenly and has spread rapidly, thus
heightening the clamor for rapid acquisition of knowledge. The illness
was first identified in 1981 and is thought to have first appeared in the
United States in 1979.60 By the end of 1984, 7,000 cases had been reported in the United States.61 The reported incidence of AIDS has
been doubling every year, with 40,000 new cases expected by the beginning of 1987.62 Although over 75 percent of American AIDS patients were residents of New York, California, Florida, or New Jersey
at the time their illness began, AIDS has been reported in forty-five
states, the District of Columbia, Puerto Rico, and twenty-one other
countries. 63 Furthermore, in Africa, heterosexual contact may be a
common means of transmission, 64 thus increasing the possibility of
spread from identified risk groups into the general population.
Fourth, the emotion attached to research about AIDS is clearly intensified by the fact that is has a fatal prognosis. AIDS is characterized by severe and apparently irreversible reduction of helper Tcells,65 which are very important for the proper functioning of the im56. Council on Scientific Affairs, The Acquired Immune Deficiency Syndrome, 252 J.
A.M.A. 2037, 2040 (1984).
57. Id. at 2042.
58. See, e.g., CDC Interview Protocol No. 577 (n.d.).
59. W. Horstman, Dilemma of Sampling a Hidden Population (Aug. 25, 1984) (paper
presented at the meeting of the Am. Psychological Ass'n, Toronto).
60. Council on Scientific Affairs, supra note 56, at 2037.
61. Office of Technology Assessment, Review of the Public Health Service's Responses to AIDS: A Technical Memorandum 6 (Feb. 1985) [hereinafter cited as
OTA].
62. Id.
63. Council on Scientific Affairs, supra note 56, at 2038.
64. Women, most of whom immigrated from Africa, comprise 40 percent of the patients with AIDS in Belgium. Only 7 percent of the identified AIDS patients in
the United States have been women. Id. at 2038.
65. Witti & Goldberg, The National Institutes of Health and Research into the Acquired Immune DeJiciency Syndrome, 98 PuB. HEALTH REP. 312, 313 (1983).
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mune system. This deficit in helper T-cells makes one highly suscepti66
ble to opportunistic infections with serious, often fatal results.
This combination of factors has led to a virtually unprecedented
push toward rapid acquisition and dissemination of research on
AIDS,67 combined with continuing concern that the process of development of knowledge-particularly breaches of confidentiality-may
actually harm participants and the groups they represent. 68 AIDS patients and groups at risk are thus caught in a dilemma in which they
have a profound desire for information that may contribute to prevention or treatment of AIDS, but also a particularly acute need for protection of privacy. Beyond these personal conflicts, the need to gather
information that may be useful in protecting the public health may
clash directly with potential participants' privacy. Protecting the public may also make participants vulnerable to harm. Thus, AIDS research presents acute conflicts of interest and principle, which make it
a useful example for study of problems of the law and ethics of
research.
B.

Recent Developments in Knowledge about AIDS

The priority placed on research on AIDS has in fact resulted in
rapid development of knowledge about the syndrome, although many
important unanswered questions remain.69 The most significant development has been the discovery of a retrovirus 70 that is believed to
be the causal agent involved in AIDS. Researchers at the National
Cancer Institute isolated the retrovirus HTLV-III (human T-cell
lymphotropic virus) from the blood of a number of patients with AIDS
66. Three fourths of the AIDS patients diagnosed before July, 1982, had died by 1984.
CDC, supra note 51, at 337. The two most common opportunistic infections that
affect AIDS patients are Pneumocystis carinii pneumonia (PCP) and Kaposi's
sarcoma (KS).
67. Then Assistant Secretary of HHS Edward Brandt, Jr. requested major journals to
expedite review of research on AIDS and announce accepted findings prior to

their publication. Batchelor, AIDS: A Public Health and Psychological Emergency, 39 Am.PsYcHOLOGIST 1279, 1281 (1984). Assistant Secretary Brandt also
ascribed top priority status to work on AIDS. Brandt, The PublicHealth Service's
Number One Priority,98 PuB. HEALTH REP. 306, (1983). However, the Office of
Technology Assessment has characterized the increased resources applied to research on AIDS as following from Congress's goading and not from a commitment in HHS, especially at the Department level. See generally OTA, supra note
61.
68. See infra notes 106-41 and accompanying text.
69. The obvious steps still missing are the development of a vaccine and an effective
treatment. OTA, supra note 61, at 5-6.
70. Retroviruses are "[v]iruses that contain RNA, not DNA, and that produce a DNA
analog of their RNA through the production of an enzyme known as 'reverse
transcriptase.' The resulting DNA is incorporated in the genetic structure of the
invaded cell, in a form referred to as the 'provirus.'" Id. at 147-48.
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or AIDS-related condition (ARC).7' In serologic surveys, antibodies
reactive with HTLV-III antigens have been found in 68 to 100 percent
of patients with AIDS, 84 to 100 percent of ptitients with AIDS-related
conditions, 22 to 65 percent of gay men, 87 percent of intravenous drug
users in one program, 56 to 72 percent of persons with hemophilia A,
and 35 percent of female sexual partners of men with AIDS.72 Fewer
than 1 percent of persons outside identified risk groups are seropositive for HTLV-III antibodies. 7 3
Although testing for the presence of antibodies against HTLV-III is
useful for the screening of blood and plasma donations,7 4 and as an
instrument for more focused research on AIDS,75 the Public Health
Service has emphasized that "the antibody test is NOT a test for
AIDS,"76 an opinion shared by the American Medical Association's
Council on Scientific Affairs. 77 The prognosis for apparently healthy
seropositive persons is uncertain. According to the Centers for Disease Control, preliminary studies show that 5 to 20 percent of seropositive gay men develop AIDS within two to five years, but this finding
may not be applicable to other risk groups. 7 8 The ambiguous meaning
of antibody test results is illustrated by the possible interpretations
71. Broder & Gallo, A PathogenicRetrovirus (HTLV-II) Linked to AIDS, 311 NEW
ENG. J. MED. 1292 (1984). See also Gallo, Salahuddin & Popovic, FrequentDetection and Isolation of Cytopathic Retroviruses (HTLVI7) from Patients with
AIDS and At Risk for AIDS, 224 Sci. 500 (1984); Popovic, Sarngadharan, Read &
Gallo, Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-II) from Patients with AIDS and Pre-AIDS, 224 Sci. 497
(1984); Sarngadharan, Popvic, Bruch, Schupbach & Gallo, Antibodies Reactive
with Human T-Lymphotropic Retroviruses (HTL V-Il) in the Serum of Patients
with AIDS, 224 Sci. 506 (1984); Schupbach, Popovic, & Gilden, SerologicAnalysis
of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-ll) Associated
with AIDS, 224 Sci. 503 (1984). AIDS prodrome, also known as pre-AIDS or the
lymphadenopathy syndrome, is characterized by "unexplained chronic lymphadenopathy, nonspecific constitutional symptoms, and in vitro immunologic abnormalities." Council on Scientific Affairs, supra note 56, at 2037. No precise
estimates of what proportion of persons with these symptoms will progress to
having AIDS can be made at this time. Id. at 2037.
72. Centers for Disease Control, ProvisionalPublicHealth Service Inter-Agency Recommendationsfor ScreeningDonated Blood and Plasmafor Antibody to the Virus Causing Acquired Immune Deficiency Syndrome, 34 MORBIDITY &
MORTALITY
WEEKLY
REP. 5, 5 (1985)
[hereinafter cited as CDC
Recommendations].
73. Id.
74. See generally id.
75. OTA, supra note 61, at 5-6 & 16-26.
76. Letter from Frank E. Young, Comm'r, Food & Drugs Admin., to physicians 2
(n.d.).
77. Council on Scientific Affairs, supra note 56, at 2039.
78. CDC Recommendations, supra note 72, at 5. This conclusion by the CDC is higly
speculative, given that there has been under two years of history of HTLV-III
testing.
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offered by a task force of the Massachusetts Department of Public
Health:
[A] positive test may indicate any of the following
1. a test is a false positive
2. a person has been infected and is protected
3. a person may harbor the virus and remain healthy
4. a person may be ill with AIDS
Similarly, a negative test may mean
1. a person has not been exposed and is not infected
2. a person may be in early stages of infection or may not be able to produce antibody to the infection
3. a test is a false negative.7 9

The isolation of HTLV-III as a probable causal agent and the availability of a test for the presence of antibodies to it are clearly important developments. However, the existence of the test has resulted in
its own ethical problems. First, because of the high rate of seropositivity in risk groups, there is the potential for misuse of the test to, for
example, screen for homosexuality. It is not difficult to imagine blood
samples gathered in employment physicals being used surreptitiously
for the purpose of employment discrimination. Similarly, there may
be threats to privacy from registries of seropositive persons maintained by blood banks.80 Second, the spectre has been raised of persons in risk groups seeking to donate blood in order to find out
whether they were seropositive and, therefore, actually heightening
the risk of contamination of the blood supply. Partially for that reason, centers have been established in many localities solely for the
purpose of conducting tests for HTLV-III antibodies.S1 Third, in view
of the uncertainty associated with interpretation of the test, informing
people as the results of their tests might cause undue distress or, if
82
negative, unwarranted complacency.
Each of these issues has affected research on AIDS. First, there
are problems of maintenance of confidentiality of antibody test results. Second, persons may seek to participate in studies on AIDS in
order to have their blood tested. Participation in such a situation
could be perceived as less than fully voluntary.8 3 Third, there is a
question of whether test results should be withheld from research participants. Because of the potential harm from breach of confidentiality and the distress engendered by positive results, gay organizations
79. MassachusettsActs to FurtherProtect the Blood Supply 2 (Feb. 14, 1985) (news
release from Mass. Dep't. of Pub. Health) [hereinafter cited as Massachusetts].
80. OTA, supra note 61, at 48-49.
81. See, e.g., Massachusetts,supra note 79, at 3.
82. See, e.g., Cunningham, AIDS Antibody Test Ignores Impact on High-Risk Groups,
APA MONITOR, Mar. 1985, at 1, 8-9.
83. The participant would be participating in order to obtain a perceived benefit, no
matter what the risks involved.
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have generally argued that persons should avoid the antibody test,8 4
which might result in a chilling of research. Even if individuals consent to the test, it is arguable that the principle of beneficience requires the withholding of this information which is undoubtedly
disturbing but of questionable benefit to them.8 5 This argument is
given greater credence by evidence that people generally have difficulty in weighing accurately such baserate information as the rates of
persons in risk groups who have seropositivity and of seropositive persons who develop AIDS.86
87
However, both the Department of Health and Human Services
and the APA Committee for the Protection of Human Participants in
Research (CPHPR)88 have concluded that test results should be available to participants. Arguing that the principle of respect for persons
and, therefore, their autonomy demanded informing participants of
test results, CPHPR issued the following guideline:
It is presumptuous of investigators to withhold potentially bad news which
may be important in future decisons by participants; 8 9 it is obligatory in such
instances to give more information, not less. Participants need to be made
aware of the uncertainty of the meaning of particular findings. Indeed, were
there certainty, the study would not need to be conducted.
In providing such information, psychologists should use their own and
their colleagues' knowledge about ways of presentation of information so as to
maximize the probability that participants will have an understanding of, for
example, the application of base rates to a calculation of risk.9 0

CPHPR also acknowledged that the principle of beneficience requires "careful attention ... to emotional responses to the informa84. Cunningham, supra note 82, at 1.
85.

Cf.C. LIDZ, A MEISEL, E. ZERUBAVEL, M. CARTER, R. SESTAK & L. ROTH, INFORMED CONSENT: A STUDY OF DECISION MAKING IN PSYCHIATRY 18-19 (1984)

(discussing therapeutic privilege) [hereinafter cited as INFORMED CONSENT].
86. For overviews of the literature on foibles in legally relevant decision making, see
Saks & Kidd, HumanInformation Processingand Adjudication: Trial by Heuristics, 15 LAw & Soc'Y REv. 123 (1980-81); Thompson, Psychological Issues in Informed Consent, in 3 MAKING HEALTH CARE DECISIONS app. H (1983)
(background paper submitted to President's Comm'n for the Study of Biomed. &
Behavioral Research). See generally L. BOURNE, R. DOMINOWSKI & E. LoFrus,
COGNITIVE PROCESSES (1979); R. HOGARTH, JUDGMENT AND CHOICE (1980); Tver-

87.

88.

89.
90.

sky & Kahneman, Judgment under Uncertainty:Heuristicsand Biases, 185 SCI.
1124 (1973).
Office for Protection from Research Risks, Nat'l Inst. of Health, Guidance for
Institutional Review Boards for AIDS Studies 3 (Dec. 26, 1984) [hereinafter cited
as OPRR].
Comm. for the Protection of Human Participants in Research, Ethical Issues in
Research on AIDS, APA MONITOR, July 1985, at 26, col. 4-5 [hereinafter cited as
CPHPR].
In the absence of knowledge about the meaning of HTLV-III, seropositive persons may want to take some precautionary steps (e.g., avoiding pregnancy). CDC
Recommendations, supra note 72, at 11.
CPHPR, supra note 88, at 26, col. 4-5.
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tion. Research on AIDS demands more than perfunctory
counseling." 91 Investigators are obligated to ensure that concerns
stimulated by the study are alleviated. 92
C. The Significance of Psychosocial Research on AIDS
The issues surrounding feedback on the results of antibody tests
suggest the obvious: perceiving that one is at risk for AIDS, actually
being at risk, having AIDS itself or an AIDS-related condition
(ARC),93 or being responsible for the care of people in one of these
groups 94 is likely to engender significant emotional reactions. Unsurprisingly, depresssion is a common correlate of AIDS,9s and there are
anecedotal reports of increased stress levels in risk groups since the
existence of AIDS become known.9 6 Response to these psychological
needs is important in itself and should be a part of treatment plans for
AIDS patients and community education efforts. 97 Research is needed
to indicate the particular psychological responses elicited by AIDS and
to demonstrate ways in which counseling and education can be conducted most effectively.98
91. Id. at 26, col. 5.
92. Id. See APA Principles, supra note 16, at 638 (Principle 9.)
93. See supra note 71. The CDC recognizes an AIDS-related complex:
A variety of chronic but nonspecific symptoms and physical findings that
appear related to AIDS, which may consist of chronic generalized
lymphadenopathy, recurrent fevers, weight loss, minor alterations in the
immune system, and minor infections. Some persons with AIDS-related
complex may develop full-blown AIDS, while in others, the condition
may represent the height of clinical illness in reaction in infection with
HTLV-III. AIDS-related complex is sometimes known as "pre-AIDS."
OTA, supra note 61, at 145-46.
94. See Furstenberg & Olson, Social Work and AIDS, 9(4) Soc. WORK IN HEALTH
CARE 45, 56-57 (1984); Morin & Batchelor, Responding to the Psychological Crisis
of AIDS, 99 PuB. HEALTH REP. 4, 8-9 (1984); Polan, Hellerstein, & Arnchin, Impact of AIDS-Related Caseson an Inpatient TherapeuticMilieu, 36 Hosp. & COMMLNiTy PSYCHIATRY 173 (1985).

95. See Dilley, Ochitill, Perl & Volbering, Findings in Psychiatric Consultations
with Patientswith Acquired Immune Deficiency Syndrome, 142 AM. J. PsYCHIATRY 82 (1985); Forstein, The Psychosocial Impact of the Acquired Immunodefwkiency Syndrome, 11 SEM. IN ONCOLOGY 77 (1984); Furstenberg & Olson,
supra note 94, at 49-52; Morin, Charles, & Malyon, The Psychological Impact of
AIDS on Gay Men, 39 Am. PSYCHOLOGIST 1288, 1288-89 (1984); Perry & Tross,
PsychiatricProblemsof AIDS Inpatients at the New York Hospita" Preliminary
Report, 99 PuB. HEALTH REP. 200 (1984).
96. Forstein, supra note 95, at 80-81; Morin, Charles & Malyon, supra note 95, at
1290-93.
97. See, ag., Forstein, supra note 95; Furstenberg & Olson, supra note 94; Goulden,
Todd, Hay & Dykes, AIDS and Community Supportive Services: Understanding
and Management of PsychologicalNeeds, 1984 MED. J. AUSTL 582; Morin, Charles
& Malyon, supra note 95.
98. See, e.g., Coates, Temoshok & Mandel, PsychosocialResearch Is Essential to Understandingand TreatingAIDS, 39 AM. PSYCHOLOGIST 1309 (1984).
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Perhaps less obviously, behavoral research may be crucial in understanding the transmission of AIDS and some aspects of the disease
process itself. First, psychological research is necessary to understand
the behavioral modes of transmission. 99 Such epidemiological research has been an important first step to identification of the nature
of the agent involved in the transmission of AIDS.100 It also may hold
the key to minimization of risk among affected groups. 01 Second,
psychological co-factors may explain a substantial proportion of the
variance in the timing of acquisition of AIDS, or whether exposed individuals become ill at all. The study of psychoneuroimmunology 0 2
may provide clues to the mechanisms of immunosuppression in
AIDS.103 Third, AIDS sometimes is accompanied by organic brain
syndromes, which themselves are serious conditions. 04 The relationship between immunosuppression and central nervous system involvement bears further investigation. Fourth, psychosocial investigation
may be useful in identifying effective strategies of health education
and medical intervention. 105 Among the topics that deserve further
study are issues in fostering lifestyle change (e.g., encouragement of
"safe sex"), reducing delay in seeking treatment, and increasing compliance with treatment plans.
99. Martin & Vance, Behavioral and PsychosocialFactorsin AIDS: Methodological
and Substantive Issues, 39 AM. PSYCHOLOGIST 1303, 1304-05 (1984).
100. Epidemiologic studies are particularly likely to give clues to the co-factors involved in the development of AIDS. OTA, supra note 61, at 20.
101. Identification of co-factors and behaviors particularly potent in the transmission
and acquisition of AIDS may give clues to behavior change strategies that will aid
in its prevention. Coates, Temoshok & Mandel, supra note 98, at 1312. See also
OTA, supra note 61, at 49-51 (discussing the role of public education for gay men
and IV drug users).
102. Psychoneuroimmunology is the study of the relationship between psychological
factors (e.g., stress) and immune functioning. See, e.g., PsYcHoNEuRoIMMUNOLOGY (R. Ander ed. 1981); Maier & Laudenslager, Stress and Health.Exploring
the Links, 19(8) PSYCHOLOGY TODAY 44 (1985).
103. See, e.g., Coates, Temoshok & Mandel, supra note 98, at 1311; Martin & Vance,
supra note 99, at 1305-06. But see OTA, supra note 61, at 42-44 (Public Health
Service has funded some studies of psychological co-factors in AIDS, but has
failed to give much attention to this area).
104. See generally Dilley, supranote 95; Kermani, Drob & Alpert, OrganicBrain Syndrome in Three Cases of Acquired Immune Deficiency Syndrome, 25 COMPREHENSIVE PSYCHIATRY 294 (1984); Nurnberg, Prudic, Fiori & Freedman,
Psychopathology ComplicatingAcquired Immune Deficiency Syndrome (AIDS),
141 AM. J. PSYCHIATRY 95 (1984); Perry & Tross, supra note 95.
105. See supra note 101.
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III. SPECIAL PROBLEMS IN PSYCHOSOCIAL
RESEARCH ON AIDS
A.

Privacy
1. Intrusiveness

Examination of the nature and epidemiology of AIDS and the
range of psychosocial research on the illness makes clear the potential
threats to privacy involved in such research. Privacy entails recognition of "zones" subsumed within boundaries of the person.lO6 Therefore, respect of persons demands respect for privacy.10 7 AIDS
research implicates two forms of privacy: control of personal information, and control over one's body and mind.1 08 As already noted,109
AIDS research inherently involves some intrusiveness in that it generally requires inquiry into topic areas, such as sexual practices, which
are almost universally recognized as personal and sensitive. When selection for the study is based on private behavior (e.g., a potential participant's sexual orientation), mere identification as a potential
participant involves some cost in privacy. Moreover, where the study
focuses on responses to AIDS, participation may involve intrusion into
private thoughts and invoke some distress that would not otherwise
have occurred.11o
In order to protect privacy, participants' control over personal information should be maintained as much as possible. Such a general
rule is obviously consistent with the principle of respect for persons
and their autonomy; it is also consonant with the principle of beneficence insofar as intrusions upon privacy have adverse psychological
effects.ill In keeping with the Ethical Principles of Psychologists,
CPHPR issued the following guidelines for research on AIDS:
In general, researchers should minimize the intrusiveness of studies insofar as
possible. Whenever possible, data should be derived from clinical interviews
and archives which would already be collected. Under most circumstances,
potential participants should be contacted only after they have volunteered
106. Privacy includes control over one's body, personal space, and personal information. Melton, Minors and Privacy: Are Legal and Psychological Concepts Compatible, 62 NEB. L. REv. 455, 458-60 (1983) (and cites therein). A somewhat
different psychological conceptualization has been offered by Laufer & Wolfe,
Privacyas a Concept and Social Issue: A MultidimensionalDevelopment Theory,
33(3) J. Soc. IssuEs 22 (1977).
107. Melton, supra note 106, at 460.
108. See supra note 106.
109. See supra notes 56-59 and accompanying text.
110. Some distress may be evoked in thinking about AIDS itself, sexual preference,
experiences of loss and powerlessness, and so forth. See, e.g., Joseph, Emmons,
Kessler, Wortman, O'Brien, Hocker & Schaefer, Coping with the Threat of AIDS:
An Approach to PsychosocialAssessment, 39 AM. PSYCHOLOGIST 1297 (1984); Morin, Charles & Malyon, supra note 95.
111. See APA Principles, supra note 16, at 638 (Principle 9g).
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directly, or permission for contact has been obtained by an appropriate intermediary who is the source for identification of the participant (e.g., personal
physician; the AIDS patient, when the population to be studied includes patients' lovers or acquaintances). When more intrusive procedures appear necessary for the conduct of a study, the researcher is especially obligated to
consider and seek advice about the merits of the study in the face of the invasion of privacy (Principles 9 and 9a). The researcher should warn potential
participants when the content of an interview or questionnaire may be disturbing (Principles 9d and 9f) and permit them to refrain from participating
or to withdraw if they choose (Principle 9g) ....
[Careful debriefing and follow-up should be undertaken to identify and prevent or alleviate stressful effects of participation (Principles 9g and 9i). 1 1 2

The need to minimize sensitive research procedures (e.g., interviewing about highly personal matters) is especially acute when participation is, or appears to be, compelled. State reporting
requirements at present extend only to basic medical and demographic information, although some sensitive information (e.g., sexual
preference) is likely to be included.113 It is conceivable, however, that
if believed to be necessary to establish the cause or mode of transmission of the illness, production of much more detailed personal information would be compelled under the state's police power to protect
the public health.14 Even if a response is not legally mandated, requests for such information by state or federal authorities may be perceived as legal requirements, especially if some information is
required. Interview protocols have been developed by the federal
Centers for Disease Control (CDC) for surveillance of AIDS patients. 115 These in fact include detailed questions about sexual experiences, drug and alcohol use, medical history, travel history, and so
forth.116 Care should be taken to ensure that participants understand
when they are free not to answer questions.31 7 When in fact some
production of information is legally compelled, the invasion of privacy
should be no greater than is necessary to meet the state's compelling
interest in the preservation of public health.-18 Under such circum112. CPHPR, supra note 88, at 26, col. 3.
113. CDC's case reporting form, OMB No. 0920-0008 (rev. Apr. 1983), includes questions about sexual orientation, sexual relationships, prison history, and IV drug
users.
114. Cf. Jacobsen v. Mass, 197 U.S. 11 (1905).
115. In public health jargon, surveillance means the interview and follow-up of patients in order to determine the pattern of transmission of an illness. Although it
does involve intrusion upon privacy, it need not imply the careful scrutiny that
the term connotes in popular usage. See Novick, At Risk for AIDS: Confulentiality in Research and Surveillance, IRB Nov.-Dec. 1984, at 10. (1984).
116. See supra note 58.
117. See APA Principles, supra note 16, at 638 (Principle 9f) ("The obligation to protect . . . [the] freedom [to decline to participate] requires careful thought and
consideration when the investigator is in a position of authority or influence over
the participant").
118. CPHPR, supra note 88, at 26, col. 3.
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stances, researchers bear a special obligation to consult with colleagues and the public about whether the need for information is so
great in a particular sense to require participation. 119 Researchers'
ethical obligations are not absolved by the imprimatur of legal or public health authorities. 12 0
2.

Confidentiality

Concerns about privacy of information do not end, of course, with
the question of how much information to solicit or compel. The participant who has produced personal information retains an interest in
controlling access to the information. Beyond the basic principle of
maintenance of individuals' autonomy in decision making in private
matters, 121 the principle of beneficence requires that researchers
make an effort to shield participants from harm that might potentially
result from their participation. 2 2 Where the content is sensitive,
preservation of confidentiality becomes critical to such protection. As
one court put it: "Revelations [to psychologists] often concern the
most intimate and embarrassing details of a patient's life, and their
public exposure may well strip him of much of his own sense of
human dignity."'23
The typical insult to privacy entailed in disclosure of identifiable
research data without the consent of the participant is exacerbated in
AIDS research by the adverse social, legal, and economic consequences that may result from breaches of confidentiality. There is
ample evidence for stigma resulting from the diagnosis itself. Despite
the available knowledge about the modes of transmission of AIDS,
health care staff have been known to tend to AIDS patients only while
wearing a mask, gown, and gloves, to refuse to draw or test their
blood, and to avoid touching them.124 The Secretary of Health and
Human Services, Margaret Heckler, even found it necessary to send a
memorandum to Social Security employees admonishing them to assist clients with AIDS, and reassuring the employees of the lack of
risk in handling clients' papers or talking with them.125 Individuals
119. Id. at 26, col. 2.
120. APA Principles, supra note 16, at 634, 638 (Principles 3d & 9c); CPHPR, supra
note 88, at 26, col. 2.
121. See supra note 37 and accompanying text. See also APA Principles, supra note
16, at 638 (Principles 9d & 9f) (noting autonomy of participant in deciding
whether to participate); Melton, supra note 106, at 488-89 (noting psychological
and ethical significance of control of access to personal information).
122. See supra note 38 and accompanying text. See also APA Principles, supra note
16, at 638 (Principle 9g).
123. Lora v. Board of Education, 74 F.R.D. 565, 571 (E.D.N.Y. 1977).
124. AIDS: Fearand Loathing, 1983 EMERGENCY MED. 157.
125. Memorandum from Margaret Heckler to all Soc. Sec. Admin. employess (July 7,
1983).
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with AIDS have been fired from their jobs, evicted from their homes,
denied dietary and nursing services in hospitals or admission at all,
and even refused mortician services after death3 26 Thus, persons with
AIDS often must face shunning by others because of their fear of
catching AIDS or their inability to deal with people who have a potentially terminal illness. The social isolation that often results when acquaintances know of the diagnosis makes coping with a serious illness
more difficult.127 Furthermore, because of the generalized, irrational
nature of fear of AIDS, some stigma may accrue from mere participation in a study about AIDS, even if one does not actually have the
illness.
Disclosure of research data, or simply the fact of participation, can
also be harmful because of the stigma to which risk groups are already
vulnerable. Gay men are widely subjected to discimination.128 Some
prominent spokespersons for the religious right have denounced homosexuality as immoral and have gone so far to say that gay persons
are a threat to society who deserve to die. 129 The public image of IV
drug users is that they are skid-row addicts who will engage in
whatever criminal behavior is necessary to maintain their habit.130
Haitian Americans find racial discrimination against them exacerbated by cultural and linguistic differences, and the widespread publicity about the influx of illegal immigrants from Haiti.131
All three of the groups initially considered to be the primary
groups at risk for AIDS are also vulnerable to legal sanctions. Gay
men face at least the threat of criminal prosecution in twenty-five
states where homosexual acts are still crimes.13 2 For IV drug users,
their drug use is illegal throughout the United States, as are the associated activities of possession and sale of drugs and drug paraphernalia.1 3 3 Some Haitian Americans are illegal immigrants, who lack
126. Drake, As Baffling Illness Spreads, So Does the Concern, Philadelphia Inquirer,
Feb. 13, 1983, at 1. See also Kang, A Hard Look: AIDS Victims Seek Help in
Court,San Francisco Examiner, Sept. 10, 1983, at A-i; Pimsleur, Mayor Furious
Over 'Dumping'of AIDS Victim, San Francisco Chron., Oct. 8, 1983, at 1.
127. Nelson, Maxey & Keith, Are We Abandoning the AIDS Patient?,1984 RN 18.
128. See generally GAY MEN: THE SOCIOLOGY OF MALE HOMOSEXUALITY (M. Levine
ed. 1979); G. GOODMAN, G. LAKEY, J. LASHOF & E. THORNE, No TURNING BACK:
LESBIAN AND GAY LIBERATION FOR THE 80's (1983).

129. A Novick, Memo on Ethical Aspects of AIDS Research (1984) (unpublished
manuscript).
130. See generally P. BARIDON, ADDICTION, CRIME, AND SOCIAL POLICY (1976); D. BELLIS, HEROIN AND POLITICIANS: THE FAILURE OF PUBLIC POLICY TO CONTROL ADDICTION IN AMERICA (1981); ADDICTION (P. Bourne ed. 1974); C. LIDZ & A.
WALKER, HEROIN, DEVIANCE, AND MORALITY (1980).

131. A. Novick, supra note 129, at 2.
132. RIGHTS OF GAY PEOPLE: THE REVISED EDITION OF THE BASIC ACLU GUIDE TO A

GAY PERSON'S RIGHTS 131 (1984).
133. A. Novick, supra note 129, at 2.
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many civil rights and are at high risk of imprisonment, deportation,
and/or loss of employment.134
Thus, when identifying information is released to legal authorities,
employers, health care workers, and others, participants in AIDS research may be harmed socially and legally. Furthermore, harm may
result if identifying information about participants is released by researchers to the CDC or other public health agencies for surveillance
purposes. If AIDS were to be considered a communicable disease with
such a grave risk for public health that quarantine for AIDS patients
would be warranted,135 CDC would be in possession of the names of
many people with AIDS through their surveillance records. Presumably, these persons would then be found and confined. This risk of infringement of liberty in the name of public health may also apply to
those individuals who have tested positive for HTLV-III antibodies
and are considered at greater risk for developing AIDS. The potential
conflict of roles for the CDC of research and enforcement led some
members of a task force convened by the Hastings Center to argue
that data collected for the government in such a sensitive context
should be collected and stored by private agencies. 136
The potential for harm may extend beyond participants to their
lovers and friends. Although not justified by current knowledge, it is
conceivable that states may make seropositivity for HTLV-III antibodies a "reportable disease." If a researcher were to report such a finding about participants, they could be required to list "contacts" they
have had, as some mandated reporting statutes for venereal disease
require.137 The contacts themselves then would be compelled to submit to an interview and medical examination.
Not only the participants and their acquaintances, but society as a
whole, ultimately may be harmed by breaches of confidentiality in research on AIDS. If potential participants perceive a risk of involuntary disclosure of their data, they may be deterred from engaging in
research, and researchers may be chilled from pursuing study of socially sensitive topics. For the short term, the search for a vaccine and
a cure for AIDS would be frustrated. For a long term, the pursuit of
socially sensitive knowledge more generally might be chilled, with ad8
verse consequences for human welfare.13
The simplest answer to the problems of confidentiality, short of
134. Id.
135. A Novick, A Consideration of the Role of Quarantine for Persons Carrying the
AIDS Agent 1 (July 1984) (unpublished manuscript).
136. Boruch, Should Private Agencies Maintain Federal Research Data, IRB Nov.Dec. 1984 at 8.
137. See 42 U.S.C. § 247c(c) (1982).
138. See Andrews v. Eli Lilly & Co., 97 F.R.D. 494 (N.D. 111. 1983); Lampshire v. Proctor & Gamble Co., 94 F.R.D. 58 (N.D. Ga. 1982).
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failing to conduct research at all, would be to keep no identifiable
data.139 However, as a practical matter, deletion of sufficient personal
information to prevent "deductive disclosures" of participants' identity may be impossible in many instances. 140 Assuming arguendo,
though, that the identity of participants can be sufficiently disguised
to make it impossible to match participant and data, the solution may
be undesirable. Although participants in AIDS research have a clear
interest in privacy, they also may be harmed by failing to keep identifiable information. The Hastings Center task force on AIDS research
noted several instances in which it is essential to keep identifiers: "(a)
the researcher may need to inform a research subject about a medical
condition requiring treatment; (b) the researcher requires linking one
set of data with other sets; (c) the researcher requires linking information gathered at different times; or (d) the researcher requires verifying the reliability of the data."'141
The first of these purposes is unlikely to be related to the research
design itself.4 2 Rather, the need to inform about medical conditions is
more likely to arise from an ethical demand to promote the welfare of
participants.143 It is important to note in that regard that, in a rapidly
developing area like AIDS research, it may not be possible to predict
when information will be of importance. For example, a particular
subgroup may appear, on analysis of the data from the instant study or
other research, to be at special risk or of special significance in understanding the illness. Without identifiers, it would be impossible to
contact the particular participants to request their involvement in further study, or to inform them of precautions or treatments that research suggests may be effective in their cases.
The remaining points mentioned by the Hastings Center group are
methodological. Certain types of research require retention of identi139. See OPRR, supra note 87, at 3.
140. Accidental deductive disclosures may be more common in AIDS research than
most other research because of the small number of available participants. There
may be only one female I.V. drug user, aged 19, with one child in a particular
program or community. However, there are methods that can be used to control
this type of disclosure, such as controlling access to lists of respondents, microaggregation, and construction of crude report categories. R. BORUCH & J. CECIL,
ASSURING THE CONFIDENTIALITY OF SOCIAL RESEARCH DATA 274 (1979).

141. Bayer, Levine & Murray, Guidelinesfor Confidentiality in Research on AIDS,
IRB Nov.-Dec. 1984, at 1, 2-3.
142. An exception would be if the study is designed to test an early intervention program. E.g., what are the effects of a health education program on seropositive but
apparently health individuals?
143. There is, of course, an ethical dilemma involved. Is it better to inform participants about a condition that has been identified in the course of a study and possibly upset them, when they might use the information to seek treatment to
correct the problem? Or is it better to avoid upsetting participants who, after all,
did not seek assessment? See APA, COMMENTARY ON ETHICAL PRINCIPLES, supra

note 6, at 61-62.
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fiers. Notably, longitudinal research144 cannot be performed without
the maintenance of identifiers, at least for the length of time covered
by the study. Longitudinal research is important in understanding the
course of AIDS. For example, the meaning of seropositivity to HTLVIII antibodies is unlikely to be known until there is adequate follow-up
across time.145 Similarly, to use a psychosocial example, longitudinal

research would be especially helpful in determining whether immunosuppression is correlated with stress. Thus, information derived
from longitudinal studies about the precise timing of development of
AIDS may provide important clues about the processes underlying the

illness.
In short, the interests of both society and the participants themselves in confidentiality are mixed. Although failure to protect confidentiality adequately may adversely affect both the pursuit or
knowledge about AIDS and the welfare of participants, failure under
all circumstances to keep identifiable information also may deter development of knowledge crucial to understanding AIDS. Such de
facto prohibition of longitudinal research and combination of data
sets1 46 would obviously be detrimental to the welfare of society and
the participants.
The one clear guideline that can be stated about keeping identifiable information is that, in order for participants' consent to the research to be valid, investigators are legally and ethically obligated to
clarify the limits of confidentiality before potential participants agree
to participate. 147 If the researcher plans to keep identifiable data, potential participants must be informed of the foreseeable risks and benefits of doing so, and given a choice of whether they want their data
stored.148 Moreover, investigators are ethically obligated to take
whatever steps are necessary prior to, during, and after the study to
minimize threats to the confidentiality of the data.
144. Longitudinal research is the term for studies in which participants are observed
at several points in time.
145. The incubation period for AIDS is apparently quite lengthy. To understand the
meaning of seropositivity will require following individuals who are HTLV-III
positive or negative for extended periods of time. The latency period for development of the illness typically may be more than two years. See Eyster, Goedert,
Sarngadharan, Weiss, Gallo & Blattner, Development and Early NaturalHistory
of HTLV-111 Antibodies in Persons with Hemophilia, 253 J. A.M.A. 2219 (1985).
146. It is not always possible to foresee when combination of data sets would be useful.
Two investigators may be working independently on a problem or a population,
in which it turns out that they might test intriguing findings by sharing data.
147. See, e.g., 45 CFR § 46.116(a)(5); APA Principles, supranote 16, at 635, 638 (Principles 5 & 9j).
148. Bayer, supra note 141, at 3; CPHPR, supra note 88, at 26, col. 4.
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Reporting the Results

The possibility of involuntary disclosure of the data raises another
ethical and legal issue: when and how the results of a study on AIDS
should be reported. If an investigator is compelled to disclose data
before a study is completed, not only is there likely to be harm from
the breach of confidentiality per se, but the study may be "spoiled." 149
Besides the costs to society and the researcher of not permitting the
completion of the study, there may be misleading impressions left by
the preliminary, incompletely analyzed data. Society as a whole or
particular groups may be led erroneously into panic or complacency,
with corresponding errors in policy.150 Results also may be used to
ostracize groups unfairly, a high risk in AIDS because affected groups
may be blamed for their vulnerability and subjected to even more
15 1
stigma.
Ethical dilemmas related to the timing and content of disclosure of
the results of a study are not limited to instances in which the production of data is compelled, whether in raw or summarized form.15 2 Indeed, the issue arises even before a study begins. Institutional review
boards (IRBs), the primary legally authorized regulatory bodies for
research with human participants,15 3 are barred from consideration of
"possible long-term effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy)"154 in determining the acceptability of a proposed study. Such
149. The necessity of making the study public may prejudice potential participants to
behave in ways that they think are consistent with the results that should be
obtained. Interruption of data collection to collate recordings consistent with a
subpoena, for example, also may necessitate a change in the design of the study.
150. Forced disclosure of research information can be very damaging to a researcher
and the public. If disclosure is sought before data are complete and properly analyzed, it could result in misleading findings. Inaccuracies in reports could cause
harm to the public by giving them misinformation, and to the researcher by damaging her standing in the academic community or jeopardizing her career. At the
least it would endager her ability to obtain participants for sensitive research. See
generally Matherne, ForcedDisclosure of Academic Research, 37 VAND. L. REv.
585 (1984).
151. Because of the prejudices already present toward the groups at risk, there may be
a tendency to misinterpret results that have not been presented with care. The
characterization of AIDS by some groups as the "gay plague," and their desire to
quarantine gay men, may lead them to publicize partial results in misleading
fashion. See Miller, Today's Scarlet Letten PublicHealth and Civil Rights in the
Age of AIDS, Boston Phoenix, Mar. 26, 1985, § 2, at 1; Payne & Risch, The Politics
of Aids, SCI. FOR THE PEOPLE, Sept.-Oct. 1984, at 17.

152. Obviously a requirement to disclose summarized data prematurely poses less
threat to participants' privacy than compelled disclosure of raw data. However,
problems remain of the researcher's loss of property interest and the public's being potentially misled.
153. 45 C.F.R. § 46.109 (1984).
154. Id. at § 46.111.
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prohibition of IRB consideration of social and political factors in the
desirability of research is probably necessary to academic freedom.155
Investigators are, however, ethically required to weigh the potential
risks and benefits-including those attached
to reporting the results6
in deciding whether to conduct a study.5
The same sort of conflict arises when the study is underway. If
preliminary data suggest an important development in knowledge
about AIDS, should the researcher report these results before the
study is completed? The researcher may feel public pressure (sometimes in the form of journalists' clamor for information) 5 7 to release
results prematurely, and substantial self-interest in maximizing the
probability of being first to report a particular phenomenon of great
public and professional interests. AIDS has in fact been the subject of
extraordinarily rapid review for grants and publication, with announcement of findings even prior to publication.58
CPHPR emphasized the need for caution in deciding whether to
release results voluntarily prior to conclusion of a study and peer
review:
In the midst of these pressures [for premature disclosure of results], it is
important that researchers not lose sight of the social sensitivity of the topic.
At minimum, no service is done by reporting data which have been inadequately analyzed or are based on a sample too small or skewed to reach reliable conclusions. Mistaken reports, even if well intended, may result in unwise
public policy, undue public alarm (or undue complacency), and stigma for affected groups. When preliminary data suggest ways of reducing risk, there
must be determination of whether the potential benefits of the possibly valid
warning are outweighed by the harm which may result from reports which
may ultimately be found to be erroneous. In a matter of great moment, there
may be an imperative to facilitate research and its dissemination, but such an
obligation is not furthered by abandonment of the principles of scientific investigation and communication. 1 5 9

Even if normal schedules for publication and release of results are
followed, the problem of how to report results remains. Because of
the significance that is likely to be attached to new findings about
AIDS, researchers bear a special obligation to identify the limitations
155. See generally Am. Ass'n of Univ. Professors, Regulations GoverningResearch on
Human Subjects: Academic Freedom and the Institutional Review Board,
ACADEME, Dec. 1981, at 358.
156. See, e.g., APA Principles, supra note 16, at 633, 637 (Principles la, 9, & 9a).
157. The pressure for information about a "hot" topic like AIDS may require researchers to pay particular attention to dissemination of findings to the media in
a way that the results will not be distorted. See Schwartz, AIDS in the Media, in
SCIENCE IN THE STREETS (D. Nelkin ed. 1984); Winsten, Science and the Media:
The Boundaries of Truth, - HEALTH AFFAIRS - (1985); Zich & Temoshok, A
Primer of Pitfalls and Opportunities in AIDS Research, in AIDS AND SOCIAL
SCIENCE (D. Feldman ed.) (forthcoming).
158. See supra note 67.
159. CPHPR, supra note 88, at 26, col. 5.
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of the research, to discuss alternative interpretations of findings, and
to retain control of the dissemination of the results insofar as possible
in order to minimize misleading reports.160 An example of the risks
involved in failure to exercise such caution came when investigators
first reported AIDS in children.' 6 ' With a boost from a J. A.M.A editorial, the investigators erroneously concluded that AIDS could be
communicated simply through close contract, with the result of creating undue anxiety and increasing pressure to segregate risk groups.162
Investigators bear a great burden to attempt to ensure that results of
research are used in the service of human welfare.163
IV. THE ADEQUACY OF LEGAL PROTECTION
OF CONFIDENTIALITY
A.

Legally Sanctioned Encroachments on Confidentiality

Although there are often competing interests, it is clear from the
preceeding discussion that forced disclosure of identifiable data in
AIDS research may have substantial costs for participants, the researcher, and society. Therefore, it is important to examine carefully
ways in which disclosure may be legally compelled. Such scrutiny
may allow investigators to foresee and, when possible, prevent unplanned disclosures,164 and help policy makers identify needs to
strengthen legal protection of the confidentiality of data gathered in
research on AIDS. Study of potential requirements for involuntary
disclosures of data is also necessary so that researchers might accurately inform potential participants as to the limits of confidentiality.
Confidences can be breached by the legal system in several ways.
Disclosure of records may be mandated by state reporting laws, agency
regulations, or federal statutes. Records may also be subject to disclosure through subpoena by the judicial, legislative, or executive branch
of government. Finally, a research participant's confidential records
may be voluntarily disclosed by the researcher. The legal system may
contribute indirectly to this "voluntary" kind of breach of confidentiality by not providing proper sanctions against such disclosures.
Perhaps the most easily foreseeable form of disclosure is pursuant
to state public health laws. Many states have mandated that physicians and hospitals report various diseases to state and local health
departments for surveillance purposes.165 The CDC is the federal
160. See APA Principles, supra note 16, at 633, (Principles la & 1c).
161. Oleske, Minnefor, Cooper, Thomas, de la Cruz, Ahdich, Guerrero, Joshi &
Desposito, Immune Deficiency in Children,249 J. A.M.A. 2345 (1983).
162. Id. at 2349. See also Fauci, The Acquired Immune Defiwiency Syndrome: The
Ever-BroadeningClinical Spectrum, 249 J. A.M.A. 2375 (1983).
163. APA Principles, supra note 16, at 633, 637 (Preamble & Principle 9).
164. Bayer, supra note 141, at 6 (Recommendation 17).
165. See, e.g., CAL. HEALTH & SAFETY CODE §§ 3122-25 (West 1979); FLA. STAT.
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agency responsible for coordinating surveillance. 166 The purpose of
surveillance is to monitor mortality trends, identify emerging risk
groups, document the geographic spread of the disease, and identify
areas where preventive efforts may be most useful.167 CDC has entered into cooperative agreements with many states for AIDS surveillance.168 More than forty states now have mandatory reporting laws
for AIDS.169 So far, these statutes have required physicians and hospitals to report only diagnosed cases of AIDS. However, given CDC's
interest in risk groups, it is conceivable that states could begin to require researchers testing for HTLV-III antibodies to report these findings. Furthermore, any physicians who conduct research on persons
with AIDS may be required to report them. Researchers conducting
epidemiological studies under contract to CDC may be required to
turn over all of their data, including indentifying information. Submitting such information to the CDC is a risk to confidentiality because the names and data are being released to a federal public health
agency, which may further disseminate the information without participants' informed consent. On at least three occasions, the CDC has
released lists of names of AIDS patients to local health agencies not
affiliated with the federal government. 170
In one of these instances, 171 names were released to the New York
Blood Center in connection with a follow-up study on whether AIDS
1
had developed in persons who received the hepatitis B vaccine. 72
This incident was followed by abundant commentary. The CDC was
accused of releasing these names by accident, 7 3 which caused an understandable uproar in the affected communities. Gay rights groups
stated that before AIDS patients can be expected to reveal details of
their sexual case histories and admit to illegal acts such as prostitution, the CDC will have to do more than say "trust us" after breaching
their confidences in such a manner. 174 The CDC retorted that the re-

166.
167.
168.
169.

§§ 381.605 & 384.06 (1981); NEB. REV. STAT. § 71-503 (1981); N.J. STAT. ANN.
§§ 26:4-2 & 26:4-15 (1976); N.Y. PUB. HEALTH LAW § 324(d) (McKinney 1974).
H.R. REP. No. 582, 98th Cong., 1st Sess. (1983).
See Novick, supra note 115.
See Panem, supra note 53, at 419.
CDC, supra note 51, at 248.

170. Marwick, Confidentiality Issues May Cloud EpidemiologicStudies of AIDS, 250

J. A.M.A. 1945 (1983).
171. In another instance, names were released to the Los Angeles health department
in connection with a "cluster study" in which investigators established that a
number of AIDS cases had occurred in individuals following sexual contacts with
other person with AIDS. In the final instance, names were released to the New
York City, Los Angeles, and San Francisco health departments to eliminate possible duplication of reporting on patients who sought care in several different cities. Marwick, supra note 170, at 1945.
172. Id. at 1945.
173. Budiansky, ConfidentialMatters, 304 NATURE 478, 478 (1983).
174. Id.
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lease was not an accident. The names were delivered by hand to a
specific physician, who was responsible for determining whether the
hepatitis B vaccine was safe. The CDC also asserted that the release
was consistent with the requirements of the Privacy Act.175 News of
the incident, rightly or wrongly, intensified distrust of CDC within the
gay community, and Congressional investigators questioned whether
CDC should have that type of identifying information in the first
place.176 Following this incident, several local health departments
adopted the policy of refusing to provide patients' names to the
CDC.177 Their reports to CDC include only number codes that can be
linked to the person's name, which the state and local health departments retain. CDC has now adopted a uniform computerized means
of encoding names to attempt to ensure that identifying information
could not be deliberately or inadvertently released. 78
The question of the proper access to CDC data is illustrative of a
more general problem of possible breach of confidentiality through
"routine uses" of data or contractual agreements with funding agencies. 179 These types of disclosures are rarely forbidden by the legal
system and are not uniformly regulated by internal procedures. An
official of an agency funding or directly conducting research may have
almost unhindered access to confidential data for program audit, secondary analysis, or routine use. For these purposes, the definition of
the "agency" may extend beyond government employees to private
contractors hired to analyze the data further or conduct an audit. Fortunately, most of these uses do not require confidential identifying
data, although privacy-related problems may emerge because of accidental deductive disclosure, and direct planned disclosure where iden18 0
tifiers are thought to be required.
Researchers conducting publicly funded research may minimize
the possibility of unnecessarily broad access to raw data by seeking to
have any audits or secondary analyses conducted on the research site,
preferably by a private contractor. Such a strategy also reduces the
possibility of public access to the data under the Freedom of Informa175. Privacy Act of 1974, Pub. L. 93-579, 88 Stat. 1896, codified at 5 U.S.C. § 552a
(1982).
176. Budiansky, supra note 173, at 478.
177. Id. at 478.
178. This system is called Soundex because the numbered code corresponds to the
sound of the name it is used to replace. While Soundex helps to prevent the
inadvertent disclosure of identifying information, the code may be broken and
the names deciphered. C. Collins, AIDS Legal Guide 22 (n.d.; printed by the
Lambda Legal Defense and Education Fund, Inc.).
179. See Privacy Act of 1974, 5 U.S.C. § 552a(a)7 (1982) (defined routine use as "the use
of... [a] record for a purpose which is compatible with the purpose for which it
was collected").
180. See Bayer, supra note 141, at 2-3.
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tion Act (FOIA).s81 Federally supported researchers are confronted
with many FOTA requests for research protocols and data from ongoing research projects. For example, requests to the National Institutes
of Health (NIH) increased from 300 in 1975 to 1,638 in 1979.182 Fortunately, this Act does not apply to matters that are specifically ex83
empted from disclosure by statute. The Privacy Act,' which will be
discussed later, places some limits on disclosures of identifying information under FOIA. However, the most effective strategy is to prevent creation of an "agency record," so that the raw data are clearly
outside the reach of FOIA.-4 It is only when the data come under
"government control" that an agency record is created for purposes of
the FOIA.1s5 Thus, insofar as reports to granting agencies can be limited to summaries and analyses of data, and audits can be performed
on site by private contractors, researchers can avoid unintended disclosure of confidential information to a myriad of government workers through routine uses and the public pursuant to the FOIA.186
Such a strategy also prevents use of the research data as a registry for
public health enforcement purposes. 8 7
Perhaps the most serious threat to confidential material is
presented by the subpoena power. Subpoenas may be issued by the
judiciary for use in a pending civil or criminal case, or by the legislature or administrative agencies for investigatory purposes. Subpoenas
of confidential information about research participants are surprisingly common. Between 1966 and 1976, at least fifty scholars were
served subpoenas in eighteen different cases, ordering them to reveal
the identities of sources and participants of research. Another thirty
scientists were threatened with subpoenas. 8 8 In a national survey of
disresearchers, about eight percent reported problems of preventing
89
closure of confidential information to government authorities..
The subpoena power represents a particularly pernicious threat to
participants' confidentiality for three reasons. First, subpoenas may
be issued for reasons that are unforeseeable and have little to do with
the purpose of the research.190 Therefore, it is often difficult to provide much usable information to potential participants about risks to
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.

Freedom of Information Act, 5 U.S.C. § 552 (1982).
D. NELKIN, supra note 11, at 38.
Privacy Act of 1974, 5 U.S.C. § 552a (1982).
See generally Morris, Sales & Berman, Research and the Freedomof Information
Act, 36 AM. PSYCHOLOGIST 819 (1981).
Forsham v. Harris, 45 U.S. 169 (1980).
Morris, Sales & Berman, supra note 184, at 826.
See Boruch, supra note 136.
D. NELKIN, supra note 11, at 51.
Id. at 51-52.
See, eg., In re Grand Jury Subpoena, 750 F.2d 223 (2d Cir. 1984) (subpoena of
records of sociology graduate student studying "The Sociology of the American
Restaurant"; fire of suspicious origin occurred in restaurant under study).
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confidentiality pursuant to subpoena. Second, when, as is the case
with most AIDS research, many participants may have engaged in illegal conduct, information gathered in the course of research may be
misused as prosecutorial leads. It is not difficult to imagine an enterprising prosecutor issuing a subpoena for the raw data in a study on
AIDS in order to assist the grand jury in investigation of illegal drug
use or sexual conduct. 19 1 Besides the deception involved, 192 which is

an unethical affront to the dignity of participants, 193 such misuses of
research data are likely to chill any research on AIDS.194 Third, because subpoenaed material may enter the public domain through admission in litigation or a legislative or administrative hearing, there is
a risk of wide dissemination of confidential information and, therefore, especially great risk of embarrassment and other adverse consequences for participants.
Finally, research participants' confidentiality may be threatened by
a researcher's voluntarily disclosing such information to others without the participants' consent. The legal system contributes to this type
of disclosure by having few, if any, sanctions against such breaches.
Persons who have their medical records used for research purposes
without their consent, are particularly at risk from this type of disclosure.1 95 However, professional self-regulation pursuant to voluntary
codes of ethics may provide protection against leaks of confidential information by researchers who have not been legally compelled to disclose the data.196
B.

Legal Means of Protecting Confidentiality
1.

Statutory Protectionof Confidentiality

197
The legal system can protect confidential data in several ways.

191. Cf. Kershaw & Small, Data Confidentiality and Privacy: Lessons from the New
Jersey Negative Income Tax Experiment, 20 PUB. POL. 281 (1972) (account of
prosecutor's subpoena of records of participants in order to discover cheating on
welfare assistance).
192. The use of the information is for a purpose other than that to which participants
consented.
193. When research is government-sponsored and data are used for the purpose of
self-incrimination, there is arguably a violation of the fifth amendment, as well as
a breach of the agreement between the investigator and the participant.
194. Because of fear of misuse of data, some gay organizations have already recommended against participation in research. OTA, supra note 61, at 48.
195. See infra notes 294-97 and accompanying text.
196. Professinal self-regulation may be regarded by some as a case of the wolves
guarding the henhouse. However, the consequences of disciplinary action by a
professional organization may be grave, especially given the interplay between
action by professional ethics committees and licensing boards. P. KEITH-SPIEGEL
& G. KoOCHER, ETHICS IN PSYCHOLOGY: PROFESSIONAL STANDARDS AND CASES 49
(1985).
197. The discussion hereinafter will focus largely on the federal statutes pertinent to

1985]

PSYCHOSOCIAL RESEARCH ON AIDS

Statutes can be designed to give all or certain researcher-subject interactions complete or partial immunity to subpoenas and other forms of
compelled disclosure. Certificates of confidentiality can be issued for
a particular research project so that all confidential material of that
study is completely protected from forced disclosure. The court can
use a balancing test to determine whether particular data should be
recognized as privileged or if it would be overly burdensome to require
disclosure. Finally, granting agencies may place limitations on researchers' voluntary disclosures.
A statute providing for absolute protection of confidential research
material would provide for all such material to be protected from
every possible compelled and voluntary disclosure. Such a statute
would, however, probably be overinclusive and result in data availability being severely curtailed even for the purpose of research which
minimally intrudes upon privacy.198 As we have already noted, countervailing interests in protection of public health may justify limited
compelled production and release of information to appropriate authorities. Nonetheless, participants' interest in privacy and the interests of the public, the researcher, and participants in the expansion of
knowledge about AIDS are likely to be frustrated in the absence of
substantial protection of confidentiality of data. The clearest protection would be afforded by a statute barring disclosure under at least
some circumstances. Several current federal statutes may offer some
protection for AIDS research: the Privacy Act, the Public Health Service Act, the Controlled Substances Act, and the Drug Abuse Office
and Treatment Act.
The Privacy Act9 9 strongly limits the FOIA by protecting information from being disclosed to the public. However, it does not offer
sufficient protection to research data. The Act applies to a narrow
range of situations and has eleven exceptions to disclosure restrictions.2 00 The Act regulates all record systems maintained by federal
social research. For reviews of state laws that protect research see Madden &
Lessen, Privacy and Confidentiality of Social Research Information, in PROCEED.
INGS OF THE CONFERENCE ON SOLUTIONS TO ETHucAL AND LEGAL PROBLEMS IN
SOCIAL RESEARCH (R. Boruch, J. Cecil & J. Ross eds. 1978); C. Knerr, Confidentiality and Behavioral Research: What to do Before the Subpoena Arrives (1978)
(paper presented at the Workshop on Research Ethics, Eastern Psychological

Ass'n Conference).
198. For needed statutory reforms and proposed model statutes, see Boness & Corder,
The Researcher-SubjectRelationship: The Need for Protection and a Model Statute, 62 GEo. L.J. 243 (1973); Nejelski & Peyser, A Proposed Researcher's Shield
Statute Text and Summary of Commentary, in SOcIAL RESEARCH IN CONFLicT
WrH LAW AND ETmIcS (P. Nejelski ed. 1976) [hereinafter cited as RESEARCH IN
CoNm CT].
199. Privacy Act of 1974, 5 U.S.C. § 552a (1982).
200. The conditions for disclosure are set forth at § 552(b) of the Privacy Act:
No agency shall disclose any record which is contained in a system of
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agencies, including research and statistical record systems. Private
record systems or those maintained by state or local governments
without federal assistance are, however, exempt from the Act. Furthermore, even research record systems that are federally funded but
not directly maintained by the funding agency are beyond protection
of the Act. Only if a federal agency subcontracts for a record system
that it otherwise would have established and maintained is the record
system regulated by the Act. Records that are not individually identifiable are not regulated by the Act. Moreover, the apparent coverage
of individually identifiable data is deceptive because what is individually identifiable is not always clear. Materials that do not contain
names, social security numbers, or other obvious identifiers may still
contain information that renders individuals' identity discoverable by
inference or deduction. Thus, about the only protection the Privacy
Act does offer is against public solicitations for information that is obviously individually identifiable, and is maintained by the federal
government.
The Drug Abuse Office and Treatment Act of 1972201 is another
statute that may offer limited protection to AIDS research. However,
this statute applies only to drug abuse prevention functions.2 02 Therefore, few, if any, AIDS research projects would be covered by this statute. Research on IV drug users might fall under the protection of this
statute, but it would have to be shown that the research somehow applied to drug abuse prevention. Disclosure under the Drug Abuse Act
records by any means of communication to any person, or to another
agency, except pursuant to a written request by, or with the prior written consent, of the individual to whom the record pertains, unless disclo-

sure of the record would be [the following are those exceptions pertinent
to research]:

(1) to those officers and employees of the agency which maintains the
record who have a need for the record in the performance of their duties;
...(5) a recipient who has provided the agency with advance adequate
written assurance that the record will be used solely as a statistical research or reporting record, and the record is to be transferred in a form
that is not individually identifiable;. . . (7) to another agency or to an
instrumentality of any governmental jurisdiction within or under the
control of the United States for a civil or criminal law enforcement activ-

ity if the activity is authorized by law, and if the head of the agency or
instrumentality has made a written request to the agency which maintains the record specifying the particular portion desired and the law enforcement activity for which the record is sought; (8) to a person
pursuant to a showing of compelling circumstances affecting the health
or safety of an individual if upon such disclosure notification is transmit-

ted to the last known address of such individual; (9) to either House or
Congress, or, to the extent of matter within its jurisdiction, any committee or subcommittee thereof, any joint committee of Congress or subcommittee of any such committee; . . . (11) pursuant to the order of a
court of competent jurisdiction.

201. 21 U.S.C. § 1175(a) (1982).
202. Id.
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is more limited than under the Privacy Act alone, but the threat of
203
subpoena is still present.
Studies that are covered by the Drug Abuse Act may also be covered by the Controlled Substances Act,204 which introduces the availability of certificates of confidentiality. Certificates of confidentiality
offer one of the best protections of confidentiality because they guard
against all compelled disclosures. However, the protection offered by
these certificates is not automatic; rather, it requires a grant of confidentiality.2 05 Moreover, changes in the implementing regulation of
the Controlled Substances Act have, unfortunately, restricted this
protection to a narrow range of law enforcement studies. 206 Therefore, it is unlikely that any AIDS research would be eligible for a
grant of confidentiality under this statute today. Prior to these
changes, protection under the Act was available to a broad range of
20
social research studies investigating issues of drug abuse. 7
The Public Health Service Act,208 which also provides for certificates of confidentiality, is more likely to provide protection to
psychosocial research on AIDS. The Public Health Service Act is the
statute most frequently cited as providing protection for private social
science research. The Act permits the Secretary of HHS to:
[A]uthorize persons engaged in research on mental health, including research
on the use and effect of alcohol and other psychoactive drugs, to protect the
privacy of individuals who are the subject of such research by withholding
from all persons not connected with the conduct of such research the names
or other identifying characteristics of such individuals. Persons so authorized
to protect the privacy of such individuals may not be compelled in any federal,
203. The statute states:
Records of the identity, diagnosis, prognosis, or treatment of any patient
which are maintained in connection with the performance of any drug
abuse prevention conducted, regulated, or directly or indirectly assisted
by any department or agency of the United States shall. . . be confidential and be disclosed only for the purposes and under the circumstances
expressly authorized ....
21 U.S.C. § 1175(a) (1982).
The "drug abuse prevention" function is defined to apply to research as well
as drug-related education, training, treatment, and rehabilitation. 42 C.F.R. § 2.1
(1984). The circumstances under which records can be disclosed include: (a) to
medical personnel when a medical emergency exists; (b) to qualified personnel
for scientific research, management adults, financial audits, or program evaluation, as long as the patients' identities are not disclosed in any way; (e) if authorized by an appropriate court order. No provision is made for the patient to
receive notice or be heard if a court is requested to authorize a subpoena. 21
U.S.C. § 1175(b) (1982).
204. 21 U.S.C. §§ 801 to 904 (1982).
205. Id. at § 872(c). See Reatig, Conjidentiality Certkficates: A Measure of Privacy
Protection, 1(3) IRB 1 (1979).
206. 21 U.S.C. § 872(a)(2)-(6) (1982); 21 C.F.R. § 1316.21 (1984).
207. R. BORUCH & J. CECIL, ASSURING THE CONFmDENTIAUrY OF SOCIAL RESEARCH
DATA 252 (1979).
208. 42 U.S.C. § 242a (1982).
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state, or local civil, criminal, administrative, legislative, or other proceedings
to identify such individuals. 2 0 9

A major limitation of the Public Health Service Act is that protection extends only to names, other identifying characteristics of participants, or "any other item or combination of data about a research
subject which could reasonably lead directly or indirectly by reference
to other information to identification of the research subject."21 0 The
research data per se are not protected. Therefore, a subpoena for the
release of all research information pertaining to a known participant
may be enforceable.2 11 However, this question has not yet been confronted by the courts.
"Mental health research" is not defined in the Public Health Service Act, but research is defined broadly as any "systematic study directed toward new or fuller knowledge of the subject studied."212
Therefore most psychosocial research on AIDS should be eligible for
protection under this statute because it is obviously intended to produce knowledge, which may be construed as relevant to the mental
health of AIDS patients or risk groups. Again, however, one of the
limitations of this type of statute is that its application is discretionary.
Researchers must apply to, and convince, the Secretary of HHS to issue a grant of confidentiality in order to protect their research data.213
Our experience is that few investigators are even aware of the possiblity of acquiring certificates of confidentiality, and fewer still go to the
trouble of applying for them.214 However, it also appears that the
existence of certificates has made some studies possible that would not
otherwise have been undertaken.2 1 5 It seems likely that adequate dissemination of information to prospective researchers about the nature
of certificates of confidentiality and the procedures for obtaining them
would help to stimulate research on sensitive topics related to mental
health and substance abuse, including AIDS.
2. JudicialProtection of Confidentiality
Statutory protection of the confidentiality of research data is preferable, not only because it provides a clear statement of policy, but
209. Id. at § 242a.
210. 42 C.F.R. § 2a(2)(g) (1984).
211. Boruch, Methods for Resolving Privacy Problems in Social Research, in ETHICAL
ISSUES IN SOCIAL SCIENCE RESEARCH (T. Beauchamp, R. Faden, R. Wallace & L.
Walters eds. 1982).
212. 42 C.F.R. § 2a(2)(c) (1984).
213. Id. at § 242a(a).
214. See also Nelson & Hedrick, The Statutory Protection of Confidential Research
Data:Synthesis and Evaluation,in SOLUTIONS TO ETHICAL AND LEGAL PROBLEMS
IN SOCIAL RESEARCH 213,223 (R. Boruch & J. Cecil eds. 1983) [hereinafter cited as
SOLUTIONS].

215. See id. at 226-29.
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also because it provides information before there is an attempt to
breach confidentiality about its limits. After a subpoena is ordered for
the production of research materials, the researcher may move that it
be quashed,2 1 6 and the court then must decide whether or not to order
compliance with the subpoena. Obviously, it is risky to rely on a
court's case-by-case judgments in protecting confidentiality.
In deciding whether to enforce a subpoena, the court must examine
and weigh many factors pursuant to prevailing procedural rules. The
rules of civil and criminal procedure are very similar in their provisions governing discovery. The Federal Rules of Civil Procedure provide that "parties may obtain discovery regarding any matter, not
privileged, which is relevant to the subject matter involved in the
21
pending action ...
- 7 The Federal Rules of Evidence maintain that
for privileges to be recognized they must be constitutionally derived,
statutorily created, recognized at common law, or, for civil proceedings, prevailing in state law.218 If no privilege is found to exist, there
is an additonal argument that can be made to protect confidentiality of
data. Rule 45(b) of the Federal Rules of Civil Procedure, and Rule
17(c) of the Rules of Criminal Procedure, provide that a subpoena can
be used to force production of documentary evidence, but a court may
quash or modify the subpoena if it is unreasonable and ("or" for criminal) oppressive. 219 Of particular importance for psychosocial research
on AIDS, discovery also may be limited if justice so demands in order
220
to protect someone from embarrassment.
Courts normally employ a three-step analysis to determine
whether a subpoena is unreasonable and oppressive. 221 First, the
court must determine that the requested information is relevant to
the case at hand. Information is relevant if it is "reasonably calculated
to lead to the discovery of admissible evidence." 222 If the researcher
can convince the court that the subpoenaed information is not relevant to the legal proceeding at hand, the information would not have
to be disclosed. Once the court has established that the subpoenaed
information is relevant, the court must analyze the requesting party's
need for the information. To ascertain need, the court must determine the importance of the information to the requesting party, including the likelihood that the requesting party could get the
216. Such action is arguably ethically required. APA Principles, supra note 16, at 634
(Principle 3d); Bayer, supra note 141, at 4 (Recommendation 10); CPHPR, supra
note 88, at 26, col. 4.
217. FED. R. Cxv. P. 26(b)(1).
218. FED. R. EvmD. 501.
219. FED. R. Crv. P. 45(b); FED. R. CRiM. P. 17(c).
220. FED. R. Crr. P. 26(c).
221. Comment, Forced Disclosure of Academic Research, 37 VAND. L. REv. 585, 596
(1984).
222. FED. R. Crv. P. 26(b)(1).
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information from another source. Once the court has determined that
the subpoenaed material is relevant and the requesting party needs
the information, the court must consider the burden that enforcement
of the subpoena would impose. The burden of showing the unreasonable and oppressive nature of the subpoena is upon the subpoenaed person. Because no single factor is conclusive evidence of
unreasonableness, courts must weigh all the factors on a case by case
basis.223
No absolute privilege has been recognized for researcher-participant interactions, although many commentators have argued that
there should be one.224 Some of the arguments for an absolute privilege will be presented briefly, since many of these points may be considered in determining unreasonableness, or a privilege recognized on
a case by case basis.
If researcher-participant communications were within the protection of the Constitution, research information would always be withheld regardless of its importance to the litigation. The most plausible
constitutional argument for an absolute researcher privilege rests on
the first amendment. Academic freedom and communications necessary for research are arguably protected by the first amendment guarantees of freedom of the press and freedom of speech. In United
States v. Doe, 225 perhaps the best known attempt to apply this argument, Samuel Popkin, a political scientist, claimed immunity from inquiries by a grand jury into his knowledge of the leaks of the Pentagon
Papers. Noting that a promise of confidentiality is sometimes necessary in order to conduct research involving human participants,
Popkin reasoned that enforcement of the subpoena would deter other
persons from disclosing private information to researchers, thereby
restricting the free flow of information protected by the first amendment. 226 Neither the First Circuit Court of Appeals in Doe, nor any
other court, has been persuaded that the flow of information to the
public would be constricted in the absence of an absolute research
privilege. 227 However, the Seventh Circuit has recognized a first
amendment right to academic freedom, such that a subpoena of data
223.

Comment, Free Press, Privacy and Privilege: Protection of Researcher-Subject

Communications,17 GEo. L. REV. 1009, 1010 (1983).
224. See supra note 198.
225. 460 F.2d 328 (1st Cir. 1972).
226. U.S. CONST. amend. I states: "Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the people peaceably to assemble,
and to petition the Government for a redress of grievances."

227. See, e.g., In re Grand Jury Subpoena Dated Jan. 4, 1984, 750 F.2d 223 (2d Cir.
1984). The court found no privilege without:
a threshold showing consisting of a detailed description of the nature and
seriousness of the scholarly study in question, of the methodology employed, of the need for assurances of confidentiality to various sources to

1985]

PSYCHOSOCIAL RESEARCH ON AIDS

collected by a university-based scholar would be constitutionally tolerable only when a compelling need for the information could be
demonstrated. 228 This argument is likely to be most persuasive when
research is ongoing (i.e., the results of the study have not yet been
published), so that a subpoena of data recordings poses a special threat
229
of intrusion into the academic enterprise.
A similar qualification limits reliance on the due process clause of
the fourteenth amendment. 23 0 Under this argument, it is claimed that
forced disclosure of data deprives a researcher of property without due
process. 23 ' Before publication, the researcher may be relying on the
research to attain enhanced standing in the academic community. The
value of the research to the investigator would be greatly diminished
if results where disclosed prematurely and scholarly publication were
therefore foreclosed. The researcher forfeits her property interest
once the results are published, because she has voluntarily released
the research to the community.
Another argument under the fourteenth amendment is that a researcher's interest in personal liberty is violated by forced disclosure
of data. The argument rests on the assumption that a "researcher has
a personal right to conduct his research free from unjustifiable interruption."23 2 No court has yet addressed this issue in the context of

forced disclosure of research.
A final constitutional argument for the recognition of a privilege
rests on the participants' rather than the researcher's rights. There is
general agreement that "[p]ublic disclosure of highly sensitive or intimate information given to the researcher in confidence can damage
the privacy interests of the subject." 233 Perhaps because it is the re-

228.
229.
230.
231.
232.
233.

conduct the study, and of the fact that the disclosure requested by the
subpoena will seriously impinge upon that confidentiality.
Id. at 225. See also Buchanan v. American Motors Corp., 697 F.2d 151 (6th Cir.
1983) (subpoena requiring expert to spend many days collating raw data was unduly burdensome; court assumed without deciding that no absolute researcher
privilege existed); Wright v. Jeep Corp, 547 F. Supp. 871 (E.D. Mich. 1982) (researcher compelled to testify); Andrews v. Eli Lilly & Co., 97 F.R.D. 494 (N.D. Ill.
1983) (manufacturer's need for evidence insufficient to justify possible chilling of
research on DES); Lampshire v. Procter & Gamble Co., 94 F.R.D. 58 (N.D. Ga.
1982) (manufacturer's need for evidence insufficient to justify intrusion upon participants' privacy). See also Branzburg v. Hayes, 408 U.S. 665 (1972) (limited journalist privilege).
Dow Chem. Co. v. Allen, 672 F.2d 1262 (7th Cir. 1982).
A subpoena of data in an ongoing study risks the necessity of changing the design
and, in effect, changing the nature of the academic inquiry. This risk is especially
great when the scope of the subpoena includes future recordings of data.
U.S. CONST. amend. XIV, § 1: "No state shall... deprive any person of life, liberty, or property, without due process of law ......
Comment, supra note 221, at 609-10.
Id. at 610.
Comment, supra note 223, at 1013.
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searcher who is in a position to contest a subpoena of research data,
this argument also has yet to be addressed by the courts. Indeed, a
hallmark of decisions on the enforcement of subpoenas of research
data has been a lack of attention to participants' interests.2 34 When
the sensitivity of research protocols has been considered, courts have
tended not to be concerned with participants' privacy per se. Rather,
courts have tried to avoid deterring participants' willingness to become involved in sensitive research and, therefore, infringing the public's and the researcher's interests in the pursuit of knowledge. 23 5
The constitutional arguments, in themselves, have been insufficient for recognition of a researcher-participant privilege. A more viable approach may be to rely upon the common law privilege, as
codified in the Federal Rules of Evidence.236 The Supreme Court has
held that, by enacting Rule 501, Congress "manifested an affirmative
intention not to freeze the law of privilege." 237 Courts are free, therefore, to develop rules of privilege on a case by case basis. In so doing,
the practice has been to rely on Dean Wigmore's four-pronged test: (1)
the communication must have originated in a confidential relationship; (2) the preservation of confidentiality must be necessary for the
full and satisfactory maintenance of the relationship; (3) the relationship must be one that is important to the community; and (4) the injury to the relationship that would accrue from breach of
confidentiality must be greater than the benefit that would be gained
for the correct disposal of the litigation. 238
Although courts have been reluctant to recognize a broad researcher-participant privilege,2 3 9 psychosocial research on AIDS is apt
generally to meet the Wigmore test. The first three prongs seem
clearly applicable. Participants are generally promised confidentiality, and that pledge is probably necessary for recruitment of partici234. The only reported case in which a subpoena has been quashed on the basis of
participants' privacy is Lampshire v. Procter & Gamble, 94 F.R.D. 58 (N.D. Ga.
1982). In a civil action for injuries resulting from toxic shock syndrome, purportedly incurred from the use of tampons, Proctor & Gamble subpoenaed the
records of the CDC. These records included "information about medical history,
personal hygiene, menstrual flow, sexual activity, contraceptive methods, history
of pregnancies, douching habits, and tampon use." Id. at 60 n.2. Lampshire was

decided on the basis of the procedural balancing test, FED. R. Civ. P. (26)(c), not
the constitutional right to privacy.
235. See, e.g., Andrews v. Eli Lilly & Co., 97 F.R.D. 494 (N.D. Ill. 1983) (records of
researcher about links between mothers' prenatal ingestion of DES and vaginal
cancer in daughters); Richards of Rockford, Inc., v. Pacific Gas & Elec. Co., 71
F.R.D. 388 (N.D. Cal. 1976) (records of confidential interviews with employees
about utility's decision making about environmental issues).
236. FED. R. EVID. 501.
237. Trammel v. United States, 445 U.S. 40, 47 (1980).
238. 8 J. WIGMORE, EVIDENCE IN TRIALS AT COMMON LAW § 2285 (3d ed. 1961).

239. See supra note 227.
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pants and receipt of candid responses. The importance of research on
AIDS to the public health is also clear. With respect to the first three
prongs, the only possible problem would be that the full explication of
the limits of confidentiality in obtaining informed consent to participate in the study may serve ironically to diminish subjective expectations of privacy. However, in view of the sensitive nature of
psychosocial research on AIDS and the potential harms that may result from disclosure of records in such research, participants still may
reasonably expect maintenance of privacy.240
The fourth prong in the Wigmore test may be more problematic,
simply because it is more unpredictable. The balancing test involved
is necessarily case-specific and dependent upon trial judge discretion.
Although it is difficult to imagine many scenarios in which the balance
would not tip toward protection of confidentiality, the range of potential needs for the research data as evidence is sufficiently great to limit
one's ability to confidently predict the reliability of Rule 501 in creating a common law privilege.
3. Administrative Protection of Confidentiality

So far we have discussed ways in which the legal system may compel breaches of confidentiality and limitations on this authority. The
legal system also may exercise control over researchers'abuse of the
privacy of participants in their studies. This regulation of reserachers'

behavior is primarily through administrative mechanisms.
Notably, proposals for research on AIDS almost invariably involve
more than minimal risk to participants, 2 41 and should be accorded full
IRB review before implementation. 242 IRBs will in turn probably find
it useful to consult with affected groups. 243 When federal funding is
requested, peer reviewers and agency officers for protection of human
participants provide additional scrutiny of the ethics of the research.
This high level of review should help to ensure that protections of confidentiality are built into the research design whenever possible, 244
and that privacy is not vulnerable simply because of investigator carelessness or ignorance.
Review of the adequacy of protections built into a research design
240. Cf. Melton, supra note 106, at 478-80, 486 (applicability of fourth amendment
should not be dependent upon subjective expectation of privacy, although instances in which such expectations are present may establish a minimum zone of
privacy).
241. Bayer, supra note 141, at 5 (Recommendation 15).
242. Id.
243. OPRR, supra note 87, at 2; Bayer, supra note 141, at 7 (Recommendation 23);
CPHPR, supra note 88, at 26, col. 2.
244. OPRR, supra note 87, at 3-4; Bayer, supra note 141, at 7 (Recommendation 17);
CPHPR, supra note 88, at 26, col. 4. For a review of methodological and legal
strategies to protect confidentiality, see generally SOLUTIONS, supra note 214.
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does not guarantee, however, that researchers will in fact exercise
proper stewardship of the data. Nonetheless, the availability of administrative remedies for unethical conduct may serve an an efficient,
effective deterrent. Agencies can tailor grant restrictions to the particular ethical issues raised by a project (e.g., the need to protect confidentiality in research on AIDS), and they can put teeth into these
restrictions through their effects on investigators' livelihood. Administrative sanctions may include: (1) termination of the grant; (2)
mandatory refund of the grant; (3) suspension of pending future
grants; (4) the attachment of the record of the incident to any application for future grants; and (5) termination of eligibility for grant
awards. 245 Researchers may remain liable for civil246 or criminal2 4 7
245. Greenstein, Federal Contractorsand Grantees: What Are Your FirstAmendment
Rights?, 24 JURIMETrIcs J. 197 (1984). There is a strong argument that all necessary restrictions on research should be imposed through the grant or contract. In
this way, the terms for disclosure can be tailored to fit the particular case. Consequently, what is covered should be unambiguous, and what is permitted or prohibited should be clear to both the researcher and the governemnt. Furthermore,
the researcher should be more informed about disclosure requirements because
the researcher is more likely to read her grant or contract than the Code of Federal Regulations. However, it is questionable whether such restrictions would be
legally binding on courts, and individual grant restrictions lack uniformity. Furthermore, granting agencies do not presently enforce possible sanctions for inappropriate voluntary disclosure.
246. Three possible civil bases exist for a subject to sue a researcher for disclosure of
her confidential data, whether the disclosure was made voluntarily or under
court order by the researcher. First, the respondent may seek a tort recovery
based on breach by the investigator of a duty not to invade her privacy by disclosing confidential information. Teitelbaum, Spurious, Tractable and Intractable
Legal Problems: A PositivistApproach to Law and Social Science Research, in
SOLUTIONS, supra note 214, at 11, 27-29. However, if disclosure was made pursuant to judicial or legislative proceedings, the disclosure is considered privileged
and is not subject to legal redress. Second, the participant might cliam that a
contract between the participant and the researcher existed and included a promise of confidentiality that was breached. Id. at 29-32. Third, a participant may
claim that the researcher acquired the sensitive information by a misrepresentation about its confidentiality. Id. at 32-36.
247. It has been suggested that "having obtained information about criminal offenses
from specific, known and identified subjects of a research project, the researchers
stand in a posture a [sic] harboring information." Wolfgang, Ethical Issues of Research in Criminology, in RESEARCH IN CoNFLICT, supra note 198, at 25, 29.
Three possible theories of liability have been propose& (1) researchers who keep
secret evidence of crimes committed by others are accessories after the fact to
those crimes; (2) they are guilty of the separate crime of misprision of felony; (3)
they are guilty of the crime of obstruction of justice. Id. at 29-30. However, researchers probably do not need to worry about these possibilities. The first does
not apply to researchers, because the most common rule is that mere failure to
give information of a crime will not, in the absence of other acts of comfort or
assistance, make one an accessory after the fact. Levering v. Commonwealth, 132
Ky. 666, 117 S.W. 253 (1909). The second possibility is unlikely because misprision
of felony has been abandoned or unrecognized in most jurisdictions. Teitelbaum,
supra note 246, at 18. The final consideration does not reach silence alone. The
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consanctions, but administrative sanctions resulting from carefully
248
structed grant restrictions are probably more likely to apply.
V. THE NEED FOR LEGAL REFORM
The need for psychosocial research on AIDS is clear. So are the
ethical and pragmatic difficulties in conducting such research, absent
guarantees of confidentiality. Keeping such policy considerations in
mind, it is useful to summarize our discussion of legal protection of,
and threats to, the privacy of participants in AIDS research.
Reporting requirements pursuant to the state's authority to protect
the public health represent the form of compelled disclosure that is
most obviously and particularly relevant to research on AIDS. In
their present form, however, these requirements may actually provide
little threat to research on AIDS. Presumably, identified AIDS patients already will have been reported, and cases diagnosed in the process of conducting research (perhaps unlikely in psychosocial
research) eventually would be reported in any event. Therefore, insofar as reporting requirements are limited to identification of AIDS patients, they are likely to create little additional threat to privacy,
although there is the possibility that requirements would be initiated
for disclosure of research data more generally (as part of the state's
surveillance of AIDS cases), or reporting of seropositivity to HTLV-III
antibodies. In such an instance, the public's need for information
about the illness must be carefully balanced against the intrusion
upon participants' privacy, and the compulsory disclosure and diffusion of personal information should be no greater than necessary to
meet the state's compelling interest in preventing the spread of AIDS
and developing an effective treatment for it. Even in such a circumstance, collection and storage of the data perhaps should be the responsibility of a private agency, so as to minimize the public's access to
personal information under the FOIA, and public health agencies'
confusion of their research and police functions.24 9
Assuming that some intrusion upon the privacy of AIDS patients
and risk groups is justifiable, the most serious risks to participants appear to emanate from the possibility of unnecessarily broad distribution of data under the guise of "routine uses," and the threat of
essence of obstruction of justice lies in the commission of acts that impede, rather
than in failure to aid, the administration of justice. Id. at 20-22. It is noteworthy

that these theories of potential criminal liability of researchers apply to attempts
to protect particpants; there are unlikely to be plausible arguments for criminal
liability for researchers who breach confidentiality.
248. Teitelbaum's review, supra note 246, makes clear that potential civil liability is
"tractable." Adminstrative remedies can be efficiently applied and based on rules
that are clearly tailored to the area of study. See supra note 245.
249. See Boruch, supra note 136; Novick, supra note 115.
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subpoena. There are few legal constraints on granting agencies, public
health agencies, and researchers themselves in how widely personal
information about participants is diffused. Perhaps IRB review and
the ethical norms of the relevant professions will act as adequate constraints on "voluntary" disclosure of personal information by agency
personnel or researchers themselves. However, even assuming that
such moral scruples are widespread, clear administrative guidelines
are needed within the relevant granting and research agencies governing access of agency staff, external researchers, and public health
officials to data gathered in studies on AIDS.
Confidentiality certificates under the Public Health Service Act
appear to offer the best advance protection currently available against
subpoenas. Researchers on psychosocial aspects of AIDS should routinely seek such grants of confidentiality. Nevertheless, as a matter of
public policy, the current program of certificates of confidentiality is
inadequate. The protection of participants should not be dependent
upon whether the researcher studying them has sufficient knowledge
of the Public Health Service Act and is sufficiently diligent to apply
for a certificate. Moreover, the uncertainty of the scope of the certificates (e.g., whether they protect the data of an individual known by
the party issuing the subpoena to have participated) places researchers
in a position in which they cannot truthfully guarantee potential participants that their communications will be immune from subpoena.
If a subpoena is issued, the researcher is obligated ethically to attempt to have it quashed. 250 Even without a certificate of confidentiality, there are a number of grounds on which to base a motion to quash.
The researcher may be able to make a successful argument that she
would be unduly burdened, or that academic freedom and her property interest in the data justify immunity from subpoena. These arguments are not likely to be uniformly persuasive, especially if the study
has already been published. The most generally applicable bases for a
claim of invulnerability of AIDS research to subpoena would appear
to be potential embarrassment to the participants greater than the
need for the information in the legal proceeding, and a common law
case-by-case privilege. Even these arguments are necessarily so casespecific as to provide little reassurance to the researcher who wishes
to promise potential participants confidentiality and protect actual
participants from harm.
In order to promote psychosocial research on AIDS and to protect
participants from undue invasion of privacy and other social, legal, and
economic harms, a statute is needed to minimize disclosure of identifi250. APA Principles, supra note 16, at 634, 635-36 (Principles 3d & 5). Note that Principle 3d gives unclear guidance about the stance psychologists should take if the
law (i.e., an enforceable subpoena) and ethics (i.e., the duty to protect confidentiality) remain in conflict.
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able personal information without the consent of participants. Action
by Congress would be the preferable approach to the gaps in current
law,251 but the state legislatures may provide some protection of participants in the meantime.252
In 1983, New York enacted a statute that seems to strike a just
balance between societal and individual interests in the conduct of research on AIDS.253 The New York law provides an absolute privilege
against admission of information gathered in AIDS research as evidence in any legal proceedings. 25 4 Whatever the merits of a researcher-participant privilege generally, 255 it seems clear to us that
the public's interest in promotion of research on AIDS and participants' interest in privacy justify an absolute privilege to protect data
gathered from human participants. Even on a case-by-case basis, it is
hard to imagine instances in which the litigants' need for information
from research data would outweigh the public's and participants' interests. Regardless, in order not to chill necessary research, the AIDS
researcher-participant privilege must be a matter of policy, and not be
dependent upon case-by-case application.
At the same time, a bar on any disclosure of information from
records of AIDS patients and research participants would unduly
hamper research. Again, the New York statute seems to strike256a
proper balance. It makes research on AIDS generally confidential,
and it specifically bars publication of data in such a way that the identities of participants can be inferred.25 7 At the same time, however,
the statute permits the commissioner of public health to give researchers access to the department's records of mandatory reports of AIDS
cases. 258 Insofar as the threat to public health is so great as to require
such disclosure, actually requiring reports is a pointless intrusion upon
patients' privacy unless the data are in fact used to increase knowledge
251. The major source of regulation of research with human participants is federal,
and regulations already exist for other special populations or situations. See, e.g.,
45 C.F.R. §§ 46.201 to 211 (1984) (fetuses and pregnant women); 45 C.F.R.
§§ 46.301 to 06 (1984) (prisoners); 45 C.F.R. § 46.401.09 (1984) (children). IRBs
look to federal regulations for guidance, and a federal approach would maximize
consistency of expectations by researchers and investigators. See Bayer, supra
note 141, at 7 (Recommendation 22). Congress's Office of Technology Assessment
has indicated the probable need for statutory protection of AIDS research. OTA,
supra note 61, at 47-48.
252. Unsurprisingly, states with large numbers of AIDS patients have been first to
enact legislation promoting and regulating research on the illness. See, e.g., CAL.
HEALTH & SAFETY CODE §§ 195-199.5 (West Cum. Supp. 1985); N.Y. PUB. HEALTH
LAW §§ 2775-79 (McKinney Cum. Sup. 1984).
253. N.Y. Pus. HEALTH LAW §§ 2775-79 (McKinney Cum. Supp. 1984).

254. Id. at § 2776(2), applying id. at § 206(j).
255.
256.
257.
258.

See supra notes 224-40 and accompanying text.
N.Y. PuB. HEALTH LAW § 2776(2) (McKinney Cum. Supp. 1984).
Id.
Id.
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about AIDS.259 Beyond this minimal use of records pursuant to public
health authority, disclosure of identifiable research data to others, including other researchers, would presumably require the informed
260
consent of the participants involved.
The one shortcoming of the New York statute is that it provides no
remedies for violation of participants' confidentiality. Administrative
262
26
sanctions should be available for grantees 1 and state employees
who so violate the law. The federal Office for Protection from Research Risks in the Department of Health and Human Services has
developed procedures for application of such sanctions that provide
for careful investigation of complaints, without undue threats to researchers' reputations in the meantime.2 63 In addition, agencies involved in research, or funding for research, on AIDS should develop
clear policies as to who may have access to the data, and procedures
for insuring that these policies are implemented. IRBs should be
charged with making certain that individual researchers have given
comparable care to the development of means of protecting human
participants in AIDS research, including, under present law, applica264
tions for certificates of confidentiality.
As suggested in Section I of this Article, some of the ethical
problems faced in psychosocial research on AIDS are inherent. The
basic conflict between societal interests and individual privacy cannot
be eradicated by new legislation. The issues involved, especially in regard to protection of confidentiality would, however, be much less
acute if adequate legal protections were in place. Until such legislation is enacted, researchers need to give careful attention to the ethical dilemmas at each step in the research, 265 and to obtain the advice
259. Unless there is a clear intent actually to use the data gathered in surveillance,
authorities arguably are exceeding their statutory authority in jurisdictions in
which the purpose of reporting is expressly noted in the statute. See, e.g., N.Y.
PuB. HEALTH LAw § 206(i)(j) (McKinney 1971) (providing for "such scientific duties and research which have for their purpose the reduction of morbidity and
mortality and the improvement of the quality of medical care through the conduction of medical audits"). There is also a plausible argument that mandatory
reporting simply for the sake of reporting violates patients' constitutional right to
privacy. The production of highly personal information is compelled without any
real state interest.
260. The statute does permit access to the records for "the conduction of medical audits." Id. at § 206(l)(j). It would be important to have clear agency policy to limit
access under this provision.
261. See supra notes 245-48 and accompanying text.
262. See supra notes 179-80 and accompanying text.
263. Such procedures were developed by OPRR to deal with allegations of scientific
fraud. C. McCarthy, Issues of Noncompliance with Human Participants Regulations (paper presented to the Sci. Pol. Forum, Am. Psychological Ass'n, Sept. 21,
1984).
264. See supra notes 241-44 and accompanying text.
265. APA Principles, supra note 16, at 637-38 (Principle 9), describes the decision
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of peers, affected groups, and the general public.266 Because confidentiality cannot be fully guaranteed, researchers should minimize use of
identifiers. When identifiers are or may be necessary for the research,
participants should be fully informed of the risks and given the option
of whether to have their data stored. In view of the potential gravity
of the consequences of the decision, special effort should be made to
ensure that consent truly is informed, competent, and voluntary.267 In
that regard, we have appended guidelines designed to meet ethical and
legal requirements for informed consent.
Finally, we should return to the point that we made at the beginning of this Article. Conflicts of interest are pervasive in psychosocial
research with human participants. The examination of these conflicts
in research on AIDS highlights the issues. Because the conflicts are
particularly stark and comple, the consequences of conducting or not
conducting research are especially serious, and the general topic is one
of great public concern. Nonetheless, the basic dilemmas are not
unique to research on AIDS or even other socially sensitive topics.
Our look at the ethical and legal context of research on AIDS raises
broader questions of the adequacy of protection of human participants
in research. Although the development in the past two decades of professional and governmental mechanisms for regulation of human remaking at each point in the research process. See also CPHPR, supra note 88, at
26, col. 2:
[It is important to note that consultation - even intensive consultation
with peers and affected groups - does not absolve the researcher of ethical responsibility for the study and its conduct, even when all legal requirements for review are met. On the other hand, careful ethical
deliberation does not, of course, abrogate the requirement to follow legal
procedures for protection of human participants. Especially when there
is persistant pressure for answers to the public health issues, researchers
need to remain ethically vigilant at all phases of the investigation.
266. See supra note 243. Consultation with affected groups serves multiple purposes:
It increases the likelihood that proper attention is given to the various
interests relevant to a decision as to whether and how a study is
designed, implemented, and reported. It also provides a means of protection of particpants from "overresearch" and undue exploitation. Extraordinary review also serves as a check on the methodological integrity
of the study, which is important not only for scientific purposes; it is also
relevant to the determination of whether the study is sufficiently promising to warrant imposition upon participants and possible threats to
their privacy. Research with gay men, for example, is less likely to result in ineffective recruitment of participants, failure to ask the most
probative questions, or misinterpretation of data (and accompanying deleterious social consequences), if representatives of gay groups are
consulted.
CPHPR supra note 88, at 26, col. 2.
267. This effort should include more than writing adequate consent forms. Diligent
efforts should be made to ensure that participants perceive themselves as having
a choice and that they understand fully the nature and potential consequence of
their decision.
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search is laudatory, these procedures are insufficient. The law should
be reformed to provide better protection of participants' privacy. Legislators, researchers, and the general public need to examine more
carefully the conflicts between individual and social good inherent in
human research.
APPENDIX
COMPOSITE GUIDELINES FOR INFORMED CONSENT
TO PSYCHOSOCIAL RESEARCH ON AIDS
A.

The Elements of Informed Consent

The solicitation of knowing, intelligent, and voluntary consent to
research is an important recognition of the autonomy of potential participants and an attempt to "humanize" the relationship between researcher and participant. 268 Careful attention to this process is
especially important in research on AIDS. Because psychosocial research on AIDS typically subjects participants to some risks, respect
for persons demands that they be permitted to make a fully informed
choice whether to participate.2 69 In particular, because confidentiality
is very difficult to guarantee in research, and participants may be
harmed by disclosure of their data, or even simply the fact of their
participation, it is essential that participants be informed as to whom
and when data may be disclosed.
There are, of course, countervailing pressures that work against
such complete honesty. For instance, if all possible harms were discussed in detail, few people may be willing to participate in such a
risky affair. Ethically, this should be a concern only insofar as participants are unduly alarmed or simply confused by a complex list of risks
and benefits;270 less than full disclosure defeats the purpose of obtaining consent. If the public's need for the research is so great that it
will be conducted despite potential participants' desires not to be involved (assuming that they are fully informed), there should be a
straightforward decision to that effect, not a deceitful pro forma exercise in obtaining "informed" consent.
A second countervailing consideration is that if the consent form is
268. See generally J. KATz, supra note 3.
269. See generally Bayer, supra note 141; CPHPR, supra note 88; OPRR, supra note
88. See also BELMONT REPORT, supra note 1, and APA Principles, supra note 16,
at 633 (Preamble) (emphasizing respect for human dignity and personal
autonomy).
270. If prospective participants are unduly alarmed, the principle of beneficence
would be doubly violated. The good of the individual would be compromised by
unnecessary stress, and social welfare would be adversely affected by the difficulty in recruiting participants and, therefore, conducting research. Insofar as
concerns of participants are justified, the solution should be, of course, to diminish risk, not to hide it.
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constructed in such a way that no promise or expectation of privacy is
created for participants, a researcher's case for maintaining confidentiality might be weakened, 2 71 and participants therefore placed at
greater risk of harm. On the other hand, promises of confidentiality
that are not based on any legal right may not be recognized and may
result in liability to the researchers for voluntary breaches of such
promises. The question to be resolved, then, is how all of these concerns can be balanced in an informed consent form. To supply guidance for resolving this issue, the legal requirements for informed
consent 272 will be presented, along with suggested strategies for complying with these specifications.
For research that requires informed consent, consent must be obtained under circumstances that provide the participant sufficient opportunity to consider whether or not to participate, and minimize the
possibility of coercion or undue influence. 273 The information that is
given to the participant must be in understandable language. 274 The
consent process may not be used to obtain express or implied waivers
of participants' rights in the event that the investigator or research
2
institution incurs liability. 75
The basic requirement for informed consent is the provision of
whatever information may be relevant to a particular participant's decision whether to participate. 276 The beginning point in this calculus
is provision of information about what the investigator proposes to do
and why he or she is conducting the study. When, as is most often the
case, the study is not for the direct benefit of the participants, such
information is relevant to potential participants' decision whether the
research is worthy of their investment of time and assumption of risk.
In their subjective value system, is the area of research one which is
worthy of study? Are the specific procedures to be employed ones
that the individual participants idiosyncratically find enjoyable, interesting, boring, painful, or repugnant? Accordingly, informed consent
requires disclosure of the nature and purpose of the research:
(1) There must be a statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject's
participation, a description of the procedures to be followed, and identification
277
of any procedures that are experimental.

In addition to knowledge of whether the research is of a sort in
which the prospective participant might have an interest, knowledge
271. See supra note 240 and accompanying text.

272.
273.
274.
275.
276.

45 C.F.R. § 46.116 (1984).
Id. See also OPRR, supra note 87 at 2.
45 C.F.R. § 46.116 (1984).
Id. See also OPRR, supra note 87, at 2.
APA Principles, supra note 16, at 638 (Principle 9d). See generally J. KATz,
supra note 3; INFORMED CONSENT, supra note 85, at 13-15.
277. 45 C.F.R. § 46.116(a)(1).
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of potential risks and benefits is necessary for participants to reach a
reasoned decision about whether to participate. 278 Therefore:
(2) There must be a description of any reasonably foreseeable risks or discomforts to the subject.
(3) There must be a description of any benefits to
the subject or to others that
2 79
may reasonably be expected from the research.

Although the specific risks to be incurred will obviously vary, research on AIDS generally includes risks resulting from breaches of
confidentiality, if they occur. For most psychosocial research on
AIDS, there also may be some discomfort from consideration of emotionally laden topics, including concerns about AIDS itself. The potential benefit of research may be more difficult to gauge, because
serendipitous findings may be the ones that have the most impact. It
should certainly be possible, however, to give participants a general
sense of what the investigator hopes to accomplish through the research (e.g., to learn more about how stress and the immune system
are related).
If as a result of their involvement participants will be deprived of
benefits, this point should also be made clear. In particular, research
on efficacy of specific preventive or therapeutic interventions may necessitate at least temporary deprivation of other interventions.28 0
When such withholding of services is part of the research design, sufficient information about the risks and benefits of those services also
must be given to permit potential participants to make an informed
decision:
(4) There must be disclosure of appropriate alternative procedures
or courses
281
of treatment, if any, that might be advantageous to the subject.

Investigators are also required to inform potential participants
about the procedures for maintaining confidentiality and the limits on
privacy:
(5) There must be a statement describing the extent, if any, to which confiden-

28 2
tiality of records identifying the subject will be maintained.

Having been informed, pursuant to the second requisite, about any
harms that may accrue from a breach of confidentiality, potential participants may now calculate how likely such a harm is to occur. Full
disclosure of the limits of confidentiality protects the participant and
278. INFORMED CONSENT, supra note 85, at 12.
279. 45 C.F.R. § 46.116(a)(2)-(3).
280. See generally Breger, Randomized Social Experiments and the Law in SOLUTIONS, supra note 214, at 17; McLean, The Effect of Informed Consent on the Ac-

ceptance of Random TreatmentAssignment in a Clinical Population,11 BEHAV.
THERAPY 129 (1980).
281. 45 C.F.R. § 46.116(a)(4) (1984).

282. Id. at § 46.116(a)(5). See also OPRR, supra note 87, at 3; APA Principles, supra
note 16, at 635-36 (Principles 5 & 9j); Bayer, supra note 141, at 3 (Recommendations 3), 6 (Recommendation 17).
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the researcher. A claim of misrepresentation can be made against researchers who promise total confidentiality but know that there is a
possibility that a court order may force such disclosure. The researcher must be candid about potential breaches of confidentiality,
while still stressing to the participant that every measure possible will
28 3
be taken to protect confidentiality.
Consent forms are commonly drawn narrowly to focus on the actual research procedures that are to take place. Researchers have only
rarely concerned themselves adequately with confidentiality issues
that may arise even after the study is completed. This disregard for
potential, if remote, breaches of confidentiality can no longer be allowed to occur, particularly in AIDS research where disclosures can
be devasting to the participants. It is clear that under current law absolute guarantees of confidentiality cannot be made. Participants
should be informed whether information will be retained after the research is completed, for how long, in what form (e.g., whether identifiers will be retained), and with what safeguards (e.g., certificates of
confidentiality), if any. Perhaps most important, all reasonably fore28 4
seeable breaches of confidentiality should be described.
Such potential disclosures of data fall into four categories. First,
there are disclosures that involve minimal risk to participants' privacy
and may occur without consent or further notice. For example, unidentified, summarized information may be disclosed to other researchers through publication. Second, disclosures may occur that do
involve significant threats to privacy, but do not require participants'
consent. In these instances (e.g., subpoena), participants should be notified of the impending disclosure if their identities remain known to
the researcher, so that they themselves may attempt to take protective
action. Third, there are disclosures requiring consent to which consent is being given by virtue of the agreement to participate in the
study. For example, if the researcher makes clear an intention to
share data with public health authorities, participants may decide
whether to participate in the study under such a condition. Care
should be taken, however, not to make potential disclosures so broad
that participants cannot make an informed decision.285 A fourth type
283. Bayer, supra note 141, at 3 (Recommendations 3, 6 & 17).
284. There is, of course, a judgment call as to what level of probability rises to "reasonably foreseeable." In respect for participants, however, investigators should err
on the side of overinclusiveness in describing risks. In view of the common legal
jeopardy of participants in AIDS research, the possibility of subpoena should be
acknowledged, in the absence of clear legal protection (e.g., a privilege statute).
285. If, for example, participants are asked whether they wish their data communicated to other researchers whenever combination of data sets may be useful, the
request is probably too vague for participants to make an informed judgment.
Participants (and researchers) cannot validly predict risks and benefits of possible future disclosures.
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of disclosure is one that will occur only with the participant's consent,
but for which consent is not now being given. In such a circumstance,
participants obviously must be contacted again, so participants must at
least give informed consent to maintenance of identifying information
and future intrusions by the researcher.
Researchers also must inform potential participants about remedies that will be available if participants are harmed as a result of their
involvement in the study:
(6) For research involving more than minimal risk, there must be an explanation as to whether any compensation or medical treatments are available if
injury occurs2 8and
if so, what they consist of, or where further information may
6
be obtained.

Thus, participants should be notified of any mental health services
that will be provided by the researchers in case of distress resulting
from the study. Information also may be provided about other sources
of help, including assistance for psychosocial concerns related to
AIDS, substance abuse, and so forth, regardless of distress resulting
from the study itself.
Finally potential participants should be assured of the voluntariness of the research and their right to make an informed decision:
(7) There should be an explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights,2and
whom to
87
contact in the event of a research-related injury to the subject.
(8) There should be a statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the participants are
otherwise entitled, and that the participants may discontinue participation at
any time without
penalty or loss of benefits to which they are otherwise
288
entitled.

B.

Procedures for Informed Consent

Investigators, granting agencies, and IRBs should give careful
thought to the procedures for obtaining informed consent, as well as
the substance of what is disclosed. In that regard, written forms are
not necessarily the optimal means of providing information and re-

cording consent. Obviously, written forms provide a largely indisputable record of the consent, so that they provide some protection to the
286. 45 C.F.R. § 46.116(a)(6) (1984). But cf. APA Principles, supra note 16, at 638
(Principle 9i) (requiringtreatment for research-related injuries).
287. 45 C.F.R. § 46.116(a)(7) (1984). See also APA Principles, supra note 16, at 638
(Principle 9g).
288. 45 C.F.R. § 46.116(a)(8) (1984). See also APA Principles, supra note 16, at 638
(Principle 9f); CPHPR, supra note 88, at 26, col. 3; OPRR, supra note 87, at 3.
Obviously, this provision - and others - do not apply if in fact participation is
compelled under the police power to protect the public health. In such an instance, full disclosure of the requirements, risks, and benefits still is deserved,
however. See Bayer, supra note 141, at 7 (Recommendation 21).

PSYCHOSOCIAL RESEARCH ON AIDS

1985]

researcher (assuming that full disclosure of relevant information is
made). However, there are two countervailing considerations.
First, participants often do not comprehend or attend carefully to
written forms.28 9 In view of the significance of the decision to be
made, the investigator bears a special obligation to ensure that consent
is truly informed. If written forms are used, special attention should
be given to their readability. 290 The written forms should be supplemented by oral discussion, 291 and consideration should be given to the
2 92
use of two-part consent forms.

Second, consent forms may themselves represent a threat to privacy. If identifying information is removed from research data, the
forms may represent the only identifiable record of participation. If

the forms are then disclosed, participants may be individually vulnerable to subpoena or other inquiry about their health, sexual behavior,
drug use, or other private behavior that may be inferred from the nature of the study. When consent forms do represent a demonstrable
threat to privacy, the federal regulations permit consent without such
293
documentation.
Of course, some situations do not legally require informed consent
at all.294 One exception to required informed consent applies to research involving the collection or study of existing data, documents,
records, pathological specimens, or diagnostic specimens. This will be
true where these sources are publicly available, or if the information is
recorded by the investigator in such a manner that participants cannot
be identified, directly or through identifiers linked to the partici2 96
pants. 295 This exception may apply to the use of medical records.
However, even without legal requirements, the researcher should be
aware of the possible harms that could be caused by the inadvertent or
deliberate disclosure of personal information from such records. If
289. INFORfD CONSENr, supra note 85, at 26-28 and cites therein.
290. For easily applicable scales to test readability, see Grundner, Two Formulasfor

Determiningthe Readabilityof Subject Consent Forms, 33 AM. PsYcHOLOGIsT 773
(1978).

Instructions for simplifying language and syntax can be found in A.

ELWomc, B. SALES & J. ALFiNi, WRITING UNDERSTANDABLE JURY LNSTRUCTIONS

(1982).
291. Roth, Lidz, Meisel, Soloff, Kaufman, Spiker & Foster, Competency to Decide

about Treatment or Researcl An Overview of Some EmpiricalData, 5 INT'L J.L.
& PsYcHIATRY 29, 48 (1982).
292. A two-part consent form includes questions at the end to ensure that potential
participants understand the information that has been disclosed. Such a form is
useful, of course, only if the investigator takes it seriously and does not "prompt"
the correct answers.
293. 45 C.F.R. § 46.117(c)(1) (1984). See also Bayer, supra note 141, at 7 (Recommendation 19).
294. 45 C.F.R. § 46.117(c) (1984).
295. Id. at § 46.101(b)(5).
296. Bayer, supra note 141, at 7 (Recommendation 20).
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possible, the researcher should contact the person whose file is to be
used and obtain consent for such use, if this is can be done without
violating the person's privacy. If the patient cannot be contacted, the
researcher should either not use the file at all, not use any identifying
information, or use every safeguard possible to protect such information. The researcher should also be prepared to accept the responsibility and consequences for any harmful disclosures. A solution to this
problem would be for physicians, and others who retain medical files
of persons with AIDS, to inform their patients that their records may
be used for research. Ideally, physicians should obtain patients' con29
sent before each such disclosure. 7

297. See generally Gordis & Gold, Privacy,Confidentiality,and the Use of the Medical
Records in Research, 207 Sci. 153 (1980).

